Introduction {#s1}
============

Meiosis gives rise to haploid gametes through two sequential rounds of nuclear division. In most eukaryotes, accurate meiotic chromosome segregation requires that every pair of homologous chromosomes attains at least one crossover (CO) recombination product, which creates a stable interhomolog connection known as a chiasma ([@bib56]). However, the total number of COs per cell is typically far too low to assure CO formation on each chromosome by a Poisson process; indeed, in many species each homolog pair undergoes only a single CO ([@bib49]). In cases where multiple COs occur per chromosome pair, they are nonrandomly far apart, a phenomenon known as 'crossover interference' ([@bib51]; [@bib76]). Despite our longstanding awareness of crossover patterning, the mechanisms that ensure this highly nonrandom process remain poorly understood and controversial.

Meiotic recombination is initiated by programmed DNA double-strand breaks (DSBs) catalyzed by the conserved topoisomerase-like enzyme Spo11 (SPO-11 in *C. elegans*) ([@bib15]; [@bib33]; [@bib32]). A subset of DSBs is processed to become COs, while the rest are repaired through alternate pathways. In several model organisms, two CO pathways have been elucidated: The 'class I' pathway, which is subject to CO assurance and interference, requires two meiosis-specific homologs of the MutS bacterial mismatch repair protein, Msh4 and Msh5, which form a complex known as MutSγ. Components of the synaptonemal complex (SC), an ordered, periodic proteinaceous structure that assembles between homologous chromosomes during meiotic prophase, are also required for class I COs. An alternate enzymatic pathway can give rise to both noncrossovers and 'class II' COs, which do not show interference.

In the nematode *C. elegans*, only class I COs normally occur, and only a single CO occurs per chromosome pair ([@bib47]). No COs occur in the absence of SC assembly ([@bib45]). Additional factors required for meiotic COs, but not for homolog pairing, synapsis, or other homologous recombination, include MSH-4 and MSH-5 ([@bib34]; [@bib90]), the cyclin-related protein COSA-1 ([@bib88]), and ZHP-3, a RING finger protein ([@bib30]).

COs act together with sister chromatid cohesion to orchestrate two successive rounds of chromosome segregation. In mammals and most other model organisms, cohesion between sister chromatids is maintained near centromeres during the first division (MI), but arm cohesion must be released to allow homologs to separate ([@bib18]). In *C. elegans*, which lacks defined centromeres, cohesion is spatially regulated downstream of CO designation. Late in meiotic prophase, the chromosome region on one side of the designated CO site becomes enriched for several proteins, including HTP-1/2, LAB-1, and REC-8, which act together to maintain cohesion through the first division. Conversely, the reciprocal chromosome region becomes depleted of these proteins but retains a stretch of SC. This 'short arm' eventually recruits the Aurora B kinase AIR-2, which is required to release cohesion and allow MI segregation ([@bib13]; [@bib19]; [@bib31]; [@bib48]; [@bib52]; [@bib69]; [@bib73]). It has been unclear whether the SC that remains along this arm contributes to regulating cohesion. The hierarchy of steps leading to this remodeling, and particularly the initial trigger for this asymmetry, are also poorly understood.

Several recent studies have indicated that structural proteins within assembled SCs are highly mobile ([@bib53]; [@bib58]; [@bib68]; [@bib81]). We have also presented evidence that this material likely assembles through regulated phase separation ([@bib68]). When SCs cannot assemble between chromosomes, as in *C. elegans* mutants lacking the essential chromosome axis protein HTP-3, or in budding yeast lacking DSBs, SC proteins self-assemble to form irregularly shaped, but internally structured, nuclear bodies known as polycomplexes ([@bib71]), which do not appear to be associated with chromosomes. Observations of *C. elegans* polycomplexes *in vivo* revealed that they behave as liquid-like droplets, in that they rapidly change shape and fuse to form larger bodies ([@bib68]). Taken together, these observations indicate that SC proteins self-assemble through regulated coacervation to form a liquid crystalline material -- defined as an ordered assembly of molecules that diffuse freely relative to each other. Normally this material preferentially assembles as a bilaterally symmetrical lamina between paired axes, but in the absence of the proper chromosomal substrate, it forms polycomplexes.

Growing evidence has implicated the SC in CO regulation, particularly in *C. elegans* ([@bib25]; [@bib40]; [@bib45]; [@bib68]; [@bib77]). The mobility of proteins within assembled SCs suggests that biochemical signals such as enzymes or posttranslational modifications could move through this material to regulate CO formation along paired chromosomes. In support of this idea, a number of crossover factors and DNA damage repair components have been found to associate with both SCs and polycomplexes. In budding yeast, these include Msh4, Msh5, Spo16, Spo22 (Zip4), Zip2, and Zip3, and the 9-1-1 complex component Mec3 ([@bib74]; [@bib79]). Zip3 is unique among these proteins in that it localizes throughout the body of polycomplexes, suggesting that it has an intrinsic affinity for SC proteins, while all other proteins reported to date appear to localize to a 'cap' or focus at the surface of polycomplexes. We observed that ZHP-3, a *C. elegans* homolog of yeast Zip3 ([@bib1]), similarly localizes throughout polycomplexes ([@bib68]). Interestingly, ZHP-3 and Zip3 share homology with Hei10 and RNF212, which have been implicated in crossover control across diverse eukaryotes ([@bib11]; [@bib14]; [@bib23]; [@bib63]; [@bib67]; [@bib83]; [@bib85]). All of these proteins contain an N-terminal RING finger domain, a central coiled-coil domain, and a C-terminal domain that is predicted to be largely unstructured.

Three paralogs of ZHP-3 are expressed in the *C. elegans* germline, but their functions have not previously been described. Here we define essential meiotic roles for these proteins. We report that this family of four paralogs, which we designate as ZHP-1--4, likely act as two heterodimeric complexes to regulate CO formation. Like ZHP-3, the other 3 proteins localize throughout SCs in early prophase, and are also recruited to polycomplexes. Together with other known and unknown factors, these ZHP proteins appear to form a signaling network that acts within the SC to ensure CO formation while limiting the number of CO-designated sites, and may thus mediate both CO assurance and CO interference. In addition, the ZHP proteins in *C. elegans* act upstream of other regulators to direct chromosome remodeling in response to crossover formation, which enables the stepwise removal of cohesion that enables two successive rounds of chromosome segregation during meiosis. Homology between the ZHP proteins and meiotic regulators from other phyla indicate that similar mechanisms likely underlie meiotic CO control in most eukaryotes, and may also play previously-unrecognized roles in regulating sister chromatid cohesion during meiosis.

Results {#s2}
=======

A family of meiotic RING finger proteins in *C. elegans* {#s2-1}
--------------------------------------------------------

As described in the Introduction, the RING finger protein ZHP-3 was initially identified as a candidate meiotic factor in *C. elegans* based on its homology to Zip3, a component of the 'synapsis initiation complex' in yeast ([@bib1]). Targeted disruption of *zhp-3* revealed that it is required for CO formation, but dispensable for homolog pairing and synapsis ([@bib30]). The *C. elegans* genome includes three additional predicted genes with the same domain structure and significant homology to ZHP-3 ([Figure 1---figure supplement 1A--B](#fig1s1){ref-type="fig"}). Several independent analyses indicate that all four genes are expressed in the germline, consistent with a role in meiosis (WormBase; ([@bib86]); S.K. and A.F.D. unpublished).

All four predicted proteins have similar N-terminal C3HC4-type RING-finger domains ([Figure 1---figure supplement 1A--B](#fig1s1){ref-type="fig"}), which are usually associated with ubiquitin E3 ligase activity ([@bib17]). The C-terminal regions of these proteins are divergent and lack obvious structural domains, but contain a number of potential post-translational modification sites ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). Based on their similarity to each other, and on evidence presented here that they function together to form a regulatory circuit, we have named these genes *zhp-1* (F55A12.10), *zhp-2* (D1081.9) and *zhp-4 *(Y39B6A.16) (*[z]{.ul}ip3* [h]{.ul}omologous [p]{.ul}rotein). This numbering reflects their physical order in the *C. elegans* genome: *zhp-1,-2,* and *-3* are clustered on Chromosome I, while *zhp-4* is on Chromosome V.

To gain insight into the evolution of these proteins, we searched for homologs in other sequenced nematode genomes ([Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}). Orthologs of each protein can be identified in *C. briggsae* and *C. remanei*, as well as in other nematode genera, indicating that these proteins diversified at least tens to hundreds of millions of years ago ([Figure 1---figure supplement 1C--D](#fig1s1){ref-type="fig"} and data not shown). Their N-terminal regions show homology to the mammalian CO regulator RNF212, and ZHP-1 and ZHP-2 are also recognized by BLAST as homologs of HEI10, which is involved in CO regulation in mammals, plants, and fungi ([@bib11]; [@bib14]; [@bib63]; [@bib65]; [@bib67], [@bib83]; [@bib85]) (data not shown).

ZHP proteins exhibit two distinct patterns of dynamic localization during meiosis {#s2-2}
---------------------------------------------------------------------------------

To investigate the ZHP proteins, we inserted epitope tags at the C-terminus of each coding sequence; these tagged proteins supported normal meiosis ([Supplementary file 1](#supp1){ref-type="supplementary-material"}, Table S1) and were readily localized by immunofluorescence with epitope-specific antibodies ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"} and [Figure 2---figure supplement 2A--B](#fig2s2){ref-type="fig"}). At meiotic entry the ZHP proteins localized to small polycomplexes, which appear prior to synapsis and contain the four known SC structural proteins, SYP-1,-2, -3, and -4 ([@bib20]; [@bib68]; [@bib71]). Once SC assembly initiated, they localized to SCs ([Figure 1](#fig1){ref-type="fig"}).

![ZHP proteins exhibit two distinct patterns of dynamic localization.\
(**A--D**) Projection images showing immunofluorescent localization of 3xFLAG tagged ZHP-1 (**A**), ZHP-2 (**B**), ZHP-3 (**C**) and ZHP-4 (**D**) relative to SCs (marked by SYP-1) and CO sites (marked by GFP-COSA-1) from mitosis to early diakinesis in the germ line. Insets in each panel show representative images of ZHP localization in (left to right) early pachytene (EP), mid-pachytene (MP), late pachytene (LP) and diplotene (Di) nuclei. Inserts show diagrams to clarify the localization patterns of ZHPs (red) from MP to Di. Gray lines, blue line and green focus represent the chromosome axis, central region of the synaptonemal complex (SC) and CO site, respectively. ZHP-1 and ZHP-2 show identical dynamics: they localize to assembling SCs, and upon the appearance of COSA-1 foci they become restricted to the short arm of each bivalent. ZHP-3 and ZHP-4 also mirror each other, localizing initially throughout the SC, and then accumulating at one site along each chromosome pair, concomitant with the appearance of COSA-1 at these sites. By late pachynema, 100% of GFP-COSA-1 foci colocalize with ZHP-4 puncta (n = 2,700 COSA-1 foci in 450 nuclei from eight gonads \[11 rows of cells per gonad\] were scored). 3F indicates 3xFLAG. Scale bars, 5 µm.](elife-30789-fig1){#fig1}

As meiosis progressed, the four proteins showed two distinct patterns of localization ([Figure 1](#fig1){ref-type="fig"}): From early prophase to mid-pachynema, ZHP-1 and -2 became brighter and more contiguous along the length of SCs, although the intensity of staining was not homogeneous. Upon the appearance of GFP-COSA-1 foci, which mark designated CO sites from mid-pachynema through diplonema ([@bib88]), ZHP-1 and -2 became confined to the SC on one side of each CO. Intriguingly, this restriction was observed in pachytene nuclei that retained SC ([Figure 1A--B](#fig1){ref-type="fig"}) and the HORMA domain proteins HTP-1/2 (data not shown) on both sides of the CO, and represents the earliest known molecular differentiation of the two chromosome domains that will become the long and short arms of the bivalent. ZHP-1 and -2 remained associated with SC proteins along the short arm of each bivalent as the SC disappeared from the long arm, and persisted as long as SC proteins were present along the short arms, through late diakinesis.

ZHP-3 and -4 exhibited a similar distribution to ZHP-1 and -2 during early prophase, but showed a distinct pattern starting at mid-pachytene, when crossover designation (the selection of one recombination intermediate as the eventual crossover site for each pair of chromosomes) is thought to occur in *C. elegans* ([Figure 1C--D](#fig1){ref-type="fig"}) ([@bib88]). Upon the detection of GFP-COSA-1 foci, which mark the subset of recombination intermediates that will become COs, ZHP-3 and -4 both accumulated at these sites and gradually disappeared from the SC along both arms of the chromosomes. These observations are largely consistent with previous characterization of ZHP-3 and a partially functional GFP-ZHP-3 fusion protein ([@bib7]; [@bib30]).

Localization of ZHPs along meiotic chromosomes depends on synaptonemal complexes {#s2-3}
--------------------------------------------------------------------------------

The SC in *C. elegans* comprises at least four proteins, known as SYP-1--4, which are mutually dependent for assembly between chromosomes or as polycomplexes. We found that none of the four ZHP proteins associated along chromosomes in *syp-1* or other *syp* mutants ([Figure 1---figure supplement 3A--C](#fig1s3){ref-type="fig"}, and data not shown). Intriguingly, in the region of the germline that normally corresponds to late pachynema, the four ZHP proteins colocalized within nuclear puncta devoid of SC proteins, indicating that the ZHPs can interact with each other in the absence of SCs or polycomplexes ([Figure 1---figure supplement 3C](#fig1s3){ref-type="fig"}, lower panel). These puncta do not coincide with known DSB repair proteins ([Figure 1---figure supplement 3D](#fig1s3){ref-type="fig"}). The ZHP proteins were also less abundant in *syp-1* mutants ([Figure 1---figure supplement 3E--K](#fig1s3){ref-type="fig"}), suggesting that their stability is enhanced by association with SCs, particularly that of ZHP-1 and -2 ([Figure 1---figure supplement 3F and J](#fig1s3){ref-type="fig"}).

Because the ZHP proteins relocalized upon CO designation ([Figure 1](#fig1){ref-type="fig"}), we examined their distribution under conditions where COs fail to occur. In mutants lacking SPO-11, MSH-5, or COSA-1, ZHPs were detected along the length of SCs through diplonema (data not shown). Thus, relocalization of the ZHPs in late prophase depends on DSBs and pro-CO factors.

ZHPs likely act as two heterodimeric complexes {#s2-4}
----------------------------------------------

To investigate the meiotic functions of the ZHP proteins, we first exploited the auxin-inducible degradation system. Each of the ZHP genes was tagged with a 3xFLAG epitope or GFP and a 44-aa degron sequence (hereafter 'AID') in a strain that expresses the F-box protein AtTIR1 throughout the germline ([@bib93]). When adult animals were transferred to plates containing 1 mM auxin, all AID-tagged proteins were robustly depleted within 1--2 hr ([Figure 2---figure supplement 1A--B](#fig2s1){ref-type="fig"}). To assess the efficacy of the knockdown, we compared meiotic chromosome segregation in hermaphrodites carrying the previously characterized *zhp-3(jf61)* null allele ([@bib30]) to auxin-treated worms expressing ZHP-3-AID-GFP ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). AID-mediated depletion of ZHP-3 quantitatively phenocopied the null allele with respect to both embryonic viability (*∆zhp-3*: 2.06 ± 0.62%; *zhp-3::AID*: 1.83 ± 0.82%) and the incidence of males among the self-progeny of hermaphrodites, which reflects X-chromosome nondisjunction ([@bib26]) (*∆zhp-3*: 43.75 ± 27.59%; *zhp-3::AID*: 37.02 ± 38.12%) ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}), indicating that auxin-induced degradation effectively eliminates the function of ZHP-3.

To determine the dependence of the ZHP proteins on each other for their localization and stability, we exposed worms to auxin for 24 hr, so that a pool of nuclei had entered and progressed through meiotic prophase in the absence of AID-tagged protein. We found that ZHP-1 and -2 depend on each other for both their chromosome association and stability ([Figure 2A--D](#fig2){ref-type="fig"}). ZHP-3 and -4 were also interdependent for their localization to chromosomes ([Figure 2E and G](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2C](#fig2s2){ref-type="fig"}). ZHP-3 was unstable in the absence of ZHP-4 ([Figure 2F](#fig2){ref-type="fig"}) and ZHP-4 levels were somewhat lower when ZHP-3 was depleted ([Figure 2H](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2D](#fig2s2){ref-type="fig"}).

![ZHPs likely act as two heterodimeric protein complexes.\
(**A--H**) Projection images of mid-pachytene and diplotene nuclei, showing the localization of ZHPs (green), with corresponding Western blots to assess protein levels in the presence and absence of their partners. SCs are marked by SYP-1 (red). Tubulin was blotted as a loading control. Localization of each ZHP to SCs was abolished when its partner was depleted by auxin treatment for 24 hr. In the absence of their partners, the ZHPs were also destabilized. Scale bars, 5 µm. (**I**) Yeast 2-hybrid interactions monitored by β-galactosidase expression reveal specific interactions between ZHP-1 and ZHP-2, and ZHP-3 and ZHP-4, respectively. No interactions were detected for other combinations. 'Empty' indicates the same vector with no insert. None control: pPC97 and pPC86 with no insert; weak control: pPC97-human RB amino acids 302--928 and pPC86-human E2F1 amino acids 342--437; moderate control: pPC97-*Drosophila* DP amino acids 1--377 and pPC86-*Drosophila* E2F amino acids 225--433; and strong control: pPC97-rat cFos amino acids 132--211 and pPC86-mouse cJun amino acids 250--325.](elife-30789-fig2){#fig2}

Other RING finger proteins such as BRCA1/BARD1 are known to act as heterodimers ([@bib9]; [@bib50]; [@bib87]). The similarity and interdependence of localization of ZHP-1 and -2, and of ZHP-3 and -4, suggested that these four proteins might function as two pairs. Using yeast two-hybrid analysis, we found that ZHP-1 and -2 indeed interact with each other, and that ZHP-3 and -4 also physically interact ([Figure 2I](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2E](#fig2s2){ref-type="fig"}). This evidence for specific pairwise physical interactions, together with their physical distributions (above) and functional analysis (below), indicate that ZHP-1 and -2 form a complex, and that ZHP-3 and -4 similarly act as a pair. Hereafter we refer to these two dimeric activities as ZHP-1/2 and ZHP-3/4 for simplicity.

ZHPs play essential roles in chiasma formation and chromosome segregation {#s2-5}
-------------------------------------------------------------------------

Using a number of established assays, we investigated the meiotic functions of these RING finger proteins. At late diakinesis, association between homologs is normally maintained by chiasmata, and six condensed bivalents can be detected in each wild-type oocyte nucleus. We exposed *zhp-AID* strains to auxin for 24 hr and then analyzed chiasma formation. Depletion of ZHP-1 or ZHP-2 yielded 8--12 DAPI-staining bodies at diakinesis, representing 4--12 univalents and 0--4 bivalents ([Figure 3A--B](#fig3){ref-type="fig"}). In contrast, depletion of ZHP-3 or ZHP-4 resulted in a complete failure of chiasma formation, indicated by the appearance of 12 achiasmate chromosomes in each nucleus ([Figure 3C--D](#fig3){ref-type="fig"}), consistent with previous characterization of ZHP-3 ([@bib7]; [@bib30]).

![ZHP proteins play a central role in chiasma formation and meiotic chromosome segregation.\
(**A--D**) Upper: DAPI-stained oocyte nuclei at late diakinesis. Each panel shows a representative nucleus. Lower: Graphs indicating the distribution of DAPI-staining bodies observed at diakinesis. ZHPs tagged with AID in a *P~sun-1~::TIR1* background were treated with or without auxin for 24 hr. In the absence of auxin, each nucleus contains six bivalents (homolog pairs held together by chiasmata). Depletion of ZHP-1 or -2 leads to a marked decrease in bivalents per nucleus (8--12 DAPI-staining bodies, or 0--4 bivalents), while depletion of ZHP-3 or -4 results in a complete loss of bivalents (12 DAPI-staining bodies). *n* is the number of nuclei scored for each condition or genotype. Depletion of ZHP-1,--2, −3 or −4 significantly increase the number of DAPI-staining bodies (\*\*\*p\<0.0001 by Chi-square test for trend). The difference between ZHP-1 depletion and ZHP-2 depletion or ZHP-3 depletion and ZHP-4 depletion is not significant (p=0.7537 and 0.9760, respectively, by Chi-square test for trend). The difference between depletion of ZHP-1 or ZHP-2 and depletion of ZHP-3 or ZHP-4 is significant (\*\*\*p\<0.0001 by Chi-square test for trend). (**E**) Frequencies of males and viable embryos observed among the whole broods in wild-type, *zhp-1*, *zhp-2* and *zhp-3* null mutant hermaphrodites. (**F--G**) Sex chromosomes and autosomes show a similar reduction in chiasma formation in the absence of ZHP-1. (**F**) High magnification images of nuclei at late diakinesis from *zhp-1* heterozygous controls and null mutant hermaphrodites, hybridized with FISH probes recognizing either the right end of X-chromosome or 5S rDNA on Chromosome V, and stained with DAPI. (**G**) Graph showing the frequency of bivalents observed for Chromosome V and the X Chromosome. 'Expected value' is the frequency for any single chromosome, given the average number of bivalents we observed, and assuming that they were distributed equally among six chromosome pairs. Data were derived from the number of DAPI-staining bodies in *zhp-1* heterozygotes and null mutants. Data are represented as mean ±SEM from three independent experiments (*n* = 103 and 145 nuclei, respectively). Significance was tested using the two-sided Student's *t*-test. Scale bars, 5 µm.](elife-30789-fig3){#fig3}

Because a few chiasmata were observed when ZHP-1-AID or ZHP-2-AID were depleted, we were concerned that these proteins might not be efficiently degraded. We therefore introduced null mutations in *zhp-1* and *zhp-2* (see Materials and methods). Homozygous mutants produced few viable progeny and a high incidence of males among the self-progeny of hermaphrodites ([Figure 3E](#fig3){ref-type="fig"}), both of which are indicative of meiotic chromosome missegregation. They also showed identical distributions of DAPI-staining bodies at diakinesis to that observed in AID-depleted animals ([Figure 3---figure supplement 1A--C](#fig3s1){ref-type="fig"} and data not shown). Additionally, both *zhp-1* and *-2* null mutants produced more viable progeny than *zhp-3* null mutants (\*\*\*p\<0.001, two-sided Student's *t*-test) ([Figure 3E](#fig3){ref-type="fig"}), consistent with a less absolute dependence of chiasma formation on ZHP-1/2 than on ZHP-3/4.

We wondered whether the few chiasmata in hermaphrodites lacking ZHP-1/2 might preferentially occur on the X chromosome, which shows some differences from autosomes in its genetic requirements for DSB induction and CO formation ([@bib89]). To investigate this, we used fluorescence *in situ* hybridization (FISH) to mark Chromosome V and the X chromosome in *zhp-1* mutants. By examining nuclei at diakinesis, we found that chiasma formation was impaired to a similar degree on both chromosomes. Our observations are quantitatively consistent with a low number of chiasmata distributed evenly among all six chromosome pairs ([Figure 3F--G](#fig3){ref-type="fig"}).

ZHP-3 was previously found to be dispensable for homologous chromosome pairing, synapsis, and DSB induction ([@bib30]). Pairing and synapsis also occurred normally in the absence of ZHP-1, -2, or -4 ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). RAD-51 foci, which mark recombination intermediates and require DSB induction ([@bib12]), were also abundant in all *zhp* mutants ([Figure 3---figure supplement 3A--F](#fig3s3){ref-type="fig"}). Thus, the high frequency of achiasmate chromosomes in the absence of ZHPs reflects defects in CO recombination downstream of pairing, synapsis, and DSBs.

Prior work has established the existence of a 'crossover assurance checkpoint' in *C. elegans* that delays meiotic progression when recombination intermediates or pro-CO factors are absent on one or more chromosomes due to defects in homolog pairing, synapsis, DSB induction, or recombination ([@bib10]; [@bib35]; [@bib89]). Activation of this checkpoint prolongs the activity of the CHK-2 kinase, resulting in an extended region and elevated number of RAD-51 foci, and a shift in the pattern of meiotic recombination, but does not perturb CO interference. We observed that phosphorylation of HIM-8 and its paralogs, a marker for CHK-2 activity, was extended when any of the ZHPs was depleted ([Figure 3---figure supplement 3G--I](#fig3s3){ref-type="fig"}), and RAD-51 foci were more abundant ([Figure 3---figure supplement 3A--F](#fig3s3){ref-type="fig"}). Thus, the crossover assurance checkpoint does not require ZHP activity.

We noted differences in the dynamics of DNA repair when ZHP-1/2 were depleted as compared to ZHP-3/4 ([Figure 3---figure supplement 3A--F](#fig3s3){ref-type="fig"}). In the absence of ZHP-3/4, RAD-51 foci reached higher peak numbers than in wild-type animals or in the absence of ZHP-1/2, but depletion of ZHP-1/2 caused a greater delay in both the accumulation and disappearance of RAD-51 foci than depletion of ZHP-3/4. Thus, the two ZHP complexes likely play distinct roles in the processing of recombination intermediates, similar to observations of HEI10 and RNF212 in mouse spermatocytes ([@bib63]).

ZHP-3/4 are essential to stabilize CO intermediates, while ZHP-1/2 restrict pro-CO activities and promote CO maturation {#s2-6}
-----------------------------------------------------------------------------------------------------------------------

To probe the role of ZHPs in recombination, we examined the cytological distributions of MSH-5, which can be detected at sites of early recombination intermediates, and COSA-1, which forms bright foci at sites designated for CO formation ([@bib88]). In wild-type and control (non-auxin-treated) worms, \~10--20 MSH-5 foci per nucleus could be detected by mid-pachytene ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}), after which six GFP-COSA-1 foci -- one per pair of chromosomes -- were observed ([Figure 4A](#fig4){ref-type="fig"}), and MSH-5 became restricted to these sites ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}), as previously described ([@bib88]). In worms depleted of ZHP-3/4, neither MSH-5 nor COSA-1 foci were detected during meiotic prophase ([Figure 4B](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"} and data not shown). This indicates that ZHP-3/4 are likely required for stable association of MutSγ with early recombination intermediates. In striking contrast, depletion of ZHP-1/2 resulted in appearance of up to \~50 MSH-5 foci and up to \~30 dim but detectable GFP-COSA-1 foci per oocyte nucleus ([Figure 4C--D](#fig4){ref-type="fig"}, and [Figure 4---figure supplement 1C--D](#fig4s1){ref-type="fig"}). Notably, the number of detectable foci increased in number as nuclei advanced from mid- to late pachytene, and then rapidly declined ([Figure 4D](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1D](#fig4s1){ref-type="fig"}).

![ZHP-3/4 are required to stabilize recombination intermediates, while ZHP-1/2 promote accumulation of pro-CO factors at a subset of intermediates during late prophase.\
(**A--F**) Low-magnification images of mid- and late pachytene nuclei stained for GFP-COSA-1 (green) and SYP-1 (red). Insets on the right showing corresponding nuclei at late pachynema. (**A**) Representative *zhp-4::AID; P~sun-1~::TIR1* germline showing six sites per nucleus marked by bright GFP-COSA-1 foci in the absence of auxin treatment. (**B**) Depletion of ZHP-4 by auxin treatment for 24 hr resulted in an absence of COSA-1 foci. (**C**) Control *zhp-1::AID; P~sun-1~::TIR1* worm showing six bright GFP-COSA-1 foci per nucleus. (**D**) Depletion of ZHP-1 by auxin treatment for 24 hr results in a large number of recombination intermediates marked by dim GFP-COSA-1 foci. Image acquisition and display were adjusted to allow the dim foci to be visualized. (**E, F**) Co-depletion of ZHP-1 and SPO-11 (**E**) or of ZHP-1 and ZHP-4 (**F**) results in an absence of COSA-1 foci. (**G**) Left: Oocyte nuclei at late diakinesis, fixed and stained with DAPI. Each panel indicates a single representative nucleus. Right: Graphs of the distribution of DAPI-staining bodies at diakinesis. Co-depletion of ZHP-1 and ZHP-4 eliminates bivalents (12 DAPI-staining bodies). The number of nuclei scored for each condition was: *n* = 84 and 104, respectively. (**H**) Quantification of COs in wild type and *zhp-1* null mutant oocytes by whole genome sequencing. *n* = 8 oocytes for each genotype. \*\*p=0.0072, Mann-Whitney test. Scale bars, 5 µm.](elife-30789-fig4){#fig4}

The dim GFP-COSA-1 foci in ZHP-1/2-depleted worms showed extensive colocalization with MSH-5 foci ([Figure 4---figure supplement 1E](#fig4s1){ref-type="fig"}). Together with prior evidence, this suggested that MSH-5 and COSA-1 colocalize at many recombination intermediates in the absence of ZHP-1/2. Indeed, it is likely that these pro-CO factors initially colocalize at all strand exchange intermediates, and that the difference in the number of detected foci of MSH-5 and COSA-1 is due to the relative sensitivity of the available detection reagents.

To validate the idea that these foci correspond to recombination intermediates, we eliminated recombination by disrupting DSB formation. We AID-tagged SPO-11 and either ZHP-1 or ZHP-2 in the same strain, and found that both proteins could be effectively co-depleted by auxin treatment ([Figure 4---figure supplement 2A](#fig4s2){ref-type="fig"} and data not shown). This abolished all MSH-5 and GFP-COSA-1 foci ([Figure 4E](#fig4){ref-type="fig"} and data not shown), supporting the idea that the dim foci observed in the absence of ZHP-1/2 are indeed recombination intermediates. Co-depletion of ZHP-1 and ZHP-4 also eliminated GFP-COSA-1 foci ([Figure 4F](#fig4){ref-type="fig"} and [Figure 4---figure supplement 2B](#fig4s2){ref-type="fig"}) and bivalent formation ([Figure 4G](#fig4){ref-type="fig"}), supporting the conclusion that ZHP-3/4 are required to stabilize MutSγ at all recombination intermediates. Depletion of ZHP-1/2 also resulted in persistence of ZHP-3 and -4 throughout SCs in late pachytene nuclei ([Figure 4---figure supplement 2C](#fig4s2){ref-type="fig"} and data not shown). These observations indicate that ZHP-1/2 are required to restrict pro-CO proteins to a single recombination intermediate along each pair of homologs during late prophase.

We next sought to understand why oocytes lacking ZHP-1/2 have abundant, dim COSA-1 foci but few bivalent chromosomes. This discrepancy could indicate that the dim foci do not mature as COs, or that they do become COs but fail to give rise to stable chiasmata. To address this, we mapped COs in *zhp-1* null mutants by whole genome sequencing (see Materials and methods). Using this genetic recombination assay, an average of 2.8 ± 1.8 (SD) COs per oocyte were detected in *zhp-1* mutants, compared to 7.3 ± 3.0 (SD) per oocyte (slightly more than the expected number of 6) in wild-type animals ([Figure 4H](#fig4){ref-type="fig"}). These data are consistent with the observed number of bivalents ([Figure 3](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), and indicate that only a small fraction of COSA-1-positive foci in *zhp-1/2* mutants mature to become COs and chiasmata.

The excess number but weak immunofluorescence of GFP-COSA-1 foci in the absence of ZHP-1/2 suggested that one or more limiting components might be distributed to an excess of recombination intermediates. We therefore wondered whether accumulation of pro-CO factors at specific recombination intermediates could be rescued by restricting the number of these intermediates. Mutations in *dsb-2* cause an age-dependent reduction in meiotic DSBs: very few RAD-51 foci and chiasmata are seen in older (48 hr post-L4) *dsb-2* hermaphrodites, while somewhat more RAD-51 foci and chiasmata are seen in younger adults ([@bib70]). We co-depleted DSB-2 and ZHP-2 using the AID system ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}), fixed worms at 24 and 48 hr post-L4, and stained for RAD-51 and GFP-COSA-1. Fewer COSA-1 foci and bivalents were observed in animals depleted for both DSB-2 and ZHP-2 than DSB-2 alone, although the number of RAD-51 foci was similar ([Figure 5A--C](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"} and data not shown). Intriguingly, while younger *dsb-2* mutant animals have more meiotic DSBs ([@bib70] and data not shown), we observed fewer bright GFP-COSA-1 foci in young ZHP-2 depleted animals: only 11% of nuclei contained a bright GFP-COSA-1 focus, compared to 49% in older animals ([Figure 5B--C](#fig5){ref-type="fig"}). The number of bivalents in these animals corresponded well with bright GFP-COSA-1 foci, and only chromosomes with bright COSA-1 foci displayed the normal hallmarks of chromosome remodeling (see below), indicating that only bright COSA-1 foci reliably mature as COs.

![CO designation in the absence of ZHP-1/2.\
(**A**) Projection images of representative late pachytene nuclei stained for GFP-COSA-1 (green) and SYP-1 (red). In the absence of DSB-2 at 24 hr post-L4, an average of 3 bright GFP-COSA-1 foci are detected in each nucleus. However, very few bright GFP-COSA-1 foci are observed when ZHP-2 is co-depleted. By 48 hr post-L4, only \~2 bright GFP-COSA-1 foci are observed per nucleus in the absence of DSB-2, and most nuclei display 0--1 bright GFP-COSA-1 focus when ZHP-2 is also depleted. (**B**) Quantification of bright GFP-COSA-1 foci at late pachynema, 24 hr post-L4. Worms of the indicated genotypes were maintained in the presence or in the absence of 1 auxin for 24 hr and then dissected for analysis. Data were derived from 4 to 8 gonads for each genotype or condition. *n* = 165, 348, 172 and 377 nuclei, respectively. The number of GFP-COSA-1 foci differed significantly between *dsb-2::AID* and *zhp-2::AID; dsb-2::AID* following auxin treatment (\*\*\*p\<0.0001 by Chi-square test for trend). (**C**) Quantification of bright GFP-COSA-1 foci in late pachytene nuclei 48 hr post-L4. Data were derived from 4 to 8 gonads for each genotype or condition. *n* = 252, 558, 263 and 416 nuclei, respectively. Depletion of ZHP-2 significantly reduces the number of GFP-COSA-1 foci in the absence of DSB-2 (\*\*\*p\<0.0001 by Chi-square test for trend). The distribution of GFP-COSA-1 foci is also significantly different between 24 hr and 48 hr post-L4 for auxin treated *zhp-2::AID; dsb-2::AID* hermaphrodites (\*\*\*p\<0.0001 by Chi-square test for trend). (**D**) Representative images of mid-pachytene (MP) and late pachytene (LP) nuclei stained for RAD-51 (yellow), GFP-COSA-1 (green), SYP-1 (red), and DNA (blue). GFP-COSA-1 foci in the absence of ZHP-1/2 was visualized following exposure of SPO-11-depleted worms to varying doses of ionizing radiation. L4 worms were maintained in the presence or in the absence of 1 mM auxin for 24 hr, followed by irradiation at the indicated dosage, and then incubated for additional 8 hr to allow irradiated nuclei to progress to late pachynema. Scale bars, 5 µm.](elife-30789-fig5){#fig5}

As another approach to examine how the number of intermediates impacts CO maturation in the absence of ZHP-1/2, we co-depleted ZHP-2 and SPO-11 to abolish programmed meiotic DSBs, and exposed these animals to varying doses of ionizing radiation. When SPO-11 alone was depleted by the AID system, GFP-COSA-1 foci and bivalents were eliminated. Following 10 Gy of radiation, a dose sufficient to ensure CO formation on most chromosomes in the absence of SPO-11, six bright GFP-COSA-1 foci were observed in each nucleus, as previously described ([@bib40]; [@bib88]) ([Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}). When SPO-11 and ZHP-2 were co-depleted, bright GFP-COSA-1 foci were observed following low doses of radiation, but these never exceeded two per nucleus ([Figure 5D](#fig5){ref-type="fig"}). At 10 Gy, only extremely dim GFP-COSA-1 foci were detected ([Figure 5D](#fig5){ref-type="fig"}).

Taken together, these observations indicate that ZHP-1/2 are dispensable for a single break to become a functional interhomolog CO, but act to limit or focus the activity of ZHP-3/4 and/or other pro-CO factors to select a single recombination intermediate on each chromosome and to ensure CO maturation in the context of excess DSBs. A higher fraction of recombination intermediates become crossovers when breaks are severely reduced, but even when very few DSBs are present, ZHP-1/2 contribute to the accumulation of pro-CO factors, which in turn promotes CO maturation.

These results indicate that ZHP-1/2 play dual roles: they restrict the accumulation of pro-CO factors to a subset of recombination intermediates and promote their accumulation at a subset of sites. We tested whether these two functions could be separated by reducing the amount of either protein. When strains carrying AID-tagged ZHP-1 or -2 were exposed to low concentrations of auxin, these proteins could be partially depleted ([Figure 5---figure supplement 2A--B](#fig5s2){ref-type="fig"} and data not shown). At very low protein levels, we saw a reduction in the number of GFP-COSA-1 foci, and never observed more than six bright COSA-1 foci per nucleus. Thus, concentrations of ZHP-1/2 required to promote accumulation of pro-CO factors are also sufficient to limit their association with recombination sites ([Figure 5---figure supplement 2C](#fig5s2){ref-type="fig"} and data not shown), indicating that these functions are tightly coupled.

ZHP-1/2 mediate chromosome remodeling in response to CO designation {#s2-7}
-------------------------------------------------------------------

As described in the Introduction, stepwise chromosome segregation in *C. elegans* meiosis requires functional differentiation of the chromosome regions on either side of the crossover. Here we report that even prior to any apparent reorganization of HTP-1/2 or SC proteins, ZHP-1/2 became restricted to the SC on one side of the CO, the presumptive short arm ([Figure 1](#fig1){ref-type="fig"} and data not shown). In addition, depletion of ZHP-1 or -2 resulted in aberrant chromosome remodeling: HTP-1/2 and SYP-1 persisted along most chromosomes, both recombinant and achiasmate ([Figure 6---figure supplement 1A--C](#fig6s1){ref-type="fig"}). These observations suggested that ZHP-1/2 might regulate chromosome remodeling, in addition to their roles in CO control.

To further probe the contribution of ZHP-1/2 to remodeling, we examined *dsb-2* mutants, in which some recombination intermediates accumulate pro-CO factors and undergo CO maturation even in the absence of ZHP-1/2. The low number of COs in *dsb-2* mutants also allows direct comparison between recombinant and nonexchange chromosomes in the same nucleus, and thus at the same cell cycle stage. As described above, at 48 h-post L4, most late pachytene nuclei in *dsb-2* mutants had either 0 or 1 COSA-1 focus. These foci also accumulated ZHP-3 and ZHP-4, which disappeared from the corresponding SCs on both sides of these sites ([Figure 6A](#fig6){ref-type="fig"} and data not shown). SC proteins and the Polo kinase PLK-2 also became enriched along these chromosomes relative to nonexchange chromosomes ([Figure 6A and D](#fig6){ref-type="fig"}), as previously described ([@bib44]; [@bib58]). We also observed that PLK-2, which plays a poorly characterized role in remodeling ([@bib24]), became co-enriched with ZHP-1/2 on one side of each CO ([Figure 6E](#fig6){ref-type="fig"}, upper panel). Similar enrichment of PLK-2 along the short arm was observed in wild-type animals ([Figure 6---figure supplement 2A--B](#fig6s2){ref-type="fig"}). This had not been apparent using PLK-2 antibodies, but was readily detected with epitope-tagged PLK-2, as recently reported ([@bib24]; [@bib58]).

![ZHP-1/2 act at the top of a hierarchy of chromosome remodeling factors.\
(**A**) Late pachytene nuclei in a *dsb-2* mutant at 48 hr post-L4, stained for ZHP-3-V5 (green) and SYP-2 (red). ZHP-3 is depleted and SYP-2 is enriched specifically along SCs with bright ZHP-3 foci. Boxed areas indicate nuclei shown at higher magnification to the right. Arrowheads in inset images indicate designated CO sites. (**B**) Late pachytene nuclei stained for ZHP-3-V5 (green), SYP-2 (red) and GFP-COSA-1 (blue). In the absence of ZHP-2 and DSB-2, ZHP-3 was still depleted from CO-designated SCs. However, enrichment of SYP proteins was not observed, (**C**) Higher-magnification images of diplotene nuclei from hermaphrodites depleted of DSB-2 alone or in combination with ZHP-2. The tissue was stained with antibodies against SYP-1 (green), HTP-1 (red) and GFP-COSA-1 (blue). In the absence of DSB-2 alone, SYP-1 and HTP-1 localized to reciprocal chromosome domains of bivalent chromosomes, as previously described ([@bib44]; [@bib48]). In worms depleted of both ZHP-2 and DSB-2, SYP-1 was restricted to CO sites at diplotene-diakinesis, while HTP-1/2 were retained on both short and long arms of bivalents. Asterisk indicates nuclear envelope staining due to cross-reactivity of our SYP-1 antibody, which becomes more prominent in late prophase. (**D and E**) Representative nuclei from the same genotypes as in (**C**), stained for PLK-2-HA (green), anti-SYP-2 (red) and GFP-COSA-1 (blue). In the absence of DSB-2, PLK-2 became enriched on CO-designated chromosomes, after which it relocalized to the short arm of CO-designated SCs at late pachynema, as recently described ([@bib58]). However, when ZHP-2 and DSB-2 were co-depleted, PLK-2 was not enriched along CO-designated chromosomes, although foci were observed at CO sites. (**F**) Representative late pachytene and diplotene nuclei from hermaphrodites depleted of PLK-2, stained for ZHP-2-HA (green), SYP-1 (red) and GFP-COSA-1 (blue). In the absence of PLK-2, CO designation and asymmetric localization of ZHP-2 were delayed, and asymmetric disassembly of the SC was severely impaired, as previously described ([@bib24]), but ZHP-2 still relocalized to the presumptive short arm during late prophase. Arrowheads indicate designated CO sites. Scale bars, 5 µm.](elife-30789-fig6){#fig6}

When we co-depleted DSB-2 and ZHP-1/2, ZHP-3 still accumulated at the few bright COSA-1 foci and was depleted from the corresponding SCs on both sides of these sites ([Figure 6B](#fig6){ref-type="fig"}). This indicates that accumulation of pro-CO factors, rather than ZHP-1/2 activity per se, leads to depletion of ZHP-3/4 from the SC. However, none of the other hallmarks of CO-induced remodeling were observed in these animals, including accumulation of SC proteins and PLK-2, and asymmetrical localization of PLK-2, HTP-1/2, and LAB-1 ([Figure 6B--E](#fig6){ref-type="fig"} and data not shown). Instead, a small focus of PLK-2 was detected at CO sites ([Figure 6E](#fig6){ref-type="fig"}, lower panel). During diplotene-diakinesis, SC proteins also became restricted to this focus, while HTP-1/2 persisted along all chromosome arms ([Figure 6C](#fig6){ref-type="fig"}, lower panel).

We also depleted PLK-2 with the AID system ([Figure 6F](#fig6){ref-type="fig"}). Under these conditions, both the accumulation of pro-CO factors at a subset of recombination intermediates and the asymmetric localization of ZHP-1/2 were delayed, but still occurred ([Figure 6F](#fig6){ref-type="fig"}, lower panel). Thus, ZHP-1/2 are required for the asymmetric localization of PLK-2, but not vice versa, placing ZHP-1/2 upstream of PLK-2 in the remodeling pathway.

Because ZHP-3/4 are strictly required for CO formation, we could not analyze their roles in chromosome remodeling. However, prior work has found that a GFP-tagged ZHP-3 transgene acts as a separation-of-function allele that is proficient for CO formation but defective for remodeling ([@bib7]).

This remodeling process ultimately leads to the spatial partitioning of cohesin complexes containing distinct kleisin subunits to reciprocal chromosome domains ([@bib72]; [@bib73]). The most mature oocyte in each gonad arm, referred to as the '−1 oocyte,' normally shows enrichment of REC-8 along the long arms of each bivalent, while COH-3/4 are retained along the short arms. In ZHP-1/2 depleted worms, REC-8 persisted along all arms, while COH-3/4 virtually disappeared by the −1 oocyte ([Figure 6---figure supplement 2C](#fig6s2){ref-type="fig"}), consistent with the absence of other 'short arm' hallmarks.

Taken together, our analysis indicates that the ZHP circuit acts at or near the top of the hierarchy that mediates chromosome remodeling in response to CO designation, and directly couples these two key mechanisms to promote proper chromosome segregation. Our observations also imply that the persistence of SC along the short arm following CO designation plays an important role in remodeling by maintaining ZHP-1/2 and PLK-2 activity along this region. Together with previous observations, our findings indicate that a biochemical signaling cascade acts in *cis* within individual SC compartments to mediate and respond to CO designation ([@bib40]; [@bib44]).

Compartmentalization of CO regulation by the synaptonemal complex {#s2-8}
-----------------------------------------------------------------

In *C. elegans* lacking the chromosome axis protein HTP-3, large polycomplexes appear shortly after meiotic entry and persist throughout meiotic prophase ([@bib21]; [@bib68]; [@bib73]). These polycomplexes recapitulate both the internal order and the liquid-like behavior of SCs, and ZHP-3 concentrates within these bodies ([@bib68]). At mid-prophase, a focus of COSA-1 appears at the surface of each polycomplex. ZHP-3 also accumulates at these foci and gradually disappears from the interior of polycomplexes. Thus, ZHP-3 and COSA-1 recapitulate the dynamic relocalization and interdependence that they show at CO sites on the surface of polycomplexes, even in the absence of DSBs or recombination intermediates ([@bib68]).

To investigate this circuitry further, we disrupted *htp-3* in various tagged strains. All 4 ZHP proteins localized throughout polycomplexes during early prophase ([Figure 7A--B](#fig7){ref-type="fig"}, and data not shown), consistent with the idea that they associate with SC proteins. In contrast to ZHP-3 ([@bib68]), ZHP-1/2 did not accumulate at COSA-1 foci, but instead remained diffusely localized throughout polycomplexes during late prophase ([Figure 7A--B](#fig7){ref-type="fig"} and data not shown). COSA-1 foci appeared during late prophase even when ZHP-1/2 were depleted, but under these conditions, ZHP-3 remained distributed throughout polycomplexes in addition to concentrating with COSA-1 ([Figure 7C](#fig7){ref-type="fig"}), further indicating that ZHP-1/2 promote the accumulation of ZHP-3/4. We also found that MSH-5 colocalized with ZHP-3/4 and COSA-1 foci on polycomplexes ([Figure 7D](#fig7){ref-type="fig"}). PLK-2 localized throughout polycomplexes even prior to the detection of COSA-1 foci, but became noticeably brighter afterwards, in the presence or absence of ZHP-1/2 ([Figure 7E--F](#fig7){ref-type="fig"}).

![Compartmentalization of CO signaling within polycomplexes.\
Polycomplexes assemble from SC proteins in meiotic nuclei of *htp-3* mutants. During late meiotic prophase, a single focus containing COSA-1 and ZHP-3 appears on each polycomplex ([@bib68]and data not shown). (**A**) ZHP-1 (not shown) and ZHP-2 (green) localize throughout polycomplexes (red) both before and after the appearance of COSA-1 foci (blue). Insets show higher magnification images of the indicated polycomplexes without (left) and with (right) COSA-1 foci. (**B,C**) Late prophase nuclei showing polycomplexes in the presence and absence of ZHP-2 (minus and plus auxin treatment, respectively). Insets show higher magnification views of the indicated polycomplexes. (**B**) In the presence of ZHP-2, ZHP-3 (green) colocalizes with COSA-1 foci (cyan) in late meiotic prophase and becomes depleted from the body of polycomplexes (red). (**C**) In the absence of ZHP-2, ZHP-3 (green) colocalizes with GFP-COSA-1, but also remains diffusely localized throughout polycomplexes. (**D**) Late prophase nuclei from *htp-3* mutants showing colocalization of MSH-5 (red) with GFP-COSA-1 foci (green) on the surface of polycomplexes (blue). (**E,F**) Late prophase nuclei from the same genotypes depicted in (**B,C**). (**E**) PLK-2 (green) localizes throughout polycomplexes (red) prior to the appearance of GFP-COSA-1 foci (blue), but staining becomes more intense in late prophase. (**F**) Depletion of ZHP-2 does not affect the localization of PLK-2 to polycomplexes. Scale bars in lower magnification images, 5 µm; in insets, 1 µm.](elife-30789-fig7){#fig7}

Together with the observations of *dsb-2* mutants described above, these findings demonstrate that key aspects of the regulatory circuit that designates a subset of recombination intermediates for CO formation act autonomously within each contiguous SC or polycomplex. Remarkably, our study indicates that this circuit is triggered within polycomplexes in response to progression of nuclei into late prophase, despite the absence of any DSBs or CO intermediates in *htp-3* mutants. These observations indicate that the 'designation' of one and only one site per compartment, which mirrors the logic of crossover assurance and interference, is an intrinsic property of this compartmentalized circuitry.

Discussion {#s3}
==========

Spatial compartmentalization of CO control {#s3-1}
------------------------------------------

Evidence that the SC behaves as a phase-separated, liquid crystalline compartment suggested how this material might act as a conduit for diffusion of biochemical signals along the interface between paired chromosomes ([@bib68]). Here we provide evidence that CO assurance, CO interference, and CO maturation are coordinately regulated by the ZHP RING finger proteins ([Figure 8](#fig8){ref-type="fig"}), all of which are concentrated within the SC. Spatial confinement of the ZHPs within this interface between homologs can explain how each pair of chromosomes in the same nucleus is regulated independently, although CO designation is normally coupled to global cell cycle signals. These results add further support to the idea that CO regulation is mediated through this liquid crystalline medium.

![Schemata for crossover control and chromosome remodeling.\
(**A**) Spatial regulation of CO designation by ZHP proteins. In early prophase, all 4 ZHPs concentrate within SCs at the interface between homologous chromosomes. DSBs are induced and homologous recombination is initiated through strand invasion. Recruitment or stabilization of MutSγ and COSA-1 at these early intermediates depends on the presence of ZHP-3/4 within the SC. As nuclei progress through mid-prophase, one such intermediate along each chromosome stochastically crosses a threshold activity level. \[We note that this is analogous to a 'cracking' event posited in a beam-film model for crossover interference ([@bib36]; [@bib92])\]. This event triggers positive and negative feedback that promotes accumulation of COSA-1, MutSγ, and ZHP-3/4 at this site. These pro-CO activities may be depleted from nearby recombination intermediates through a wave of inhibitory activity that travels outward from a designated CO site; alternatively, local activation and lateral inhibition may give rise to a periodic pattern of pro-CO activity along each pair of chromosomes. In either scenario, diffusion of proteins within the SC permits coordinated behavior of potential CO sites along each pair of chromosomes. (**B**) A circuit diagram for CO control and chromosome remodeling, incorporating the findings of this work. Coupled positive and negative feedback mechanisms mediated by ZHPs and other factors lead to accumulation of pro-CO factors at a single designated crossover site. ZHP-1/2 also act at the top of a hierarchy that leads to PLK-2 enrichment on one side of the crossover and retention of the SC within this domain, creating another positive feedback loop, although how ZHP-1/2 become enriched on one side of the crossover is currently unknown. Activities within the SC antagonize the retention of HTP-1/2 and associated factors along the axis, and vice versa, resulting in the differentiation of two distinct chromosome domains. This leads to eventual removal of REC-8 from the short arm and its retention on the long arm, promoting accurate, stepwise meiotic chromosome separation.](elife-30789-fig8){#fig8}

CO interference in *C. elegans* normally limits COs to one per homolog pair. This 'winner takes all' logic is reminiscent of other well-studied biological symmetry-breaking circuits, such as the selection of a single bud site by growing *S. cerevisiae* cells ([@bib22]; [@bib28]; [@bib55]). Our evidence indicates that ZHP-1/2 are crucial for both positive feedback that promotes accumulation of pro-CO factors, including ZHP-3/4, at a single recombination intermediate, and negative feedback that depletes these factors from other candidate sites ([Figure 8](#fig8){ref-type="fig"}). Similar feedback loops have been proposed in previous work on crossover regulation ([@bib63]; [@bib65]; [@bib67]; [@bib88]). Indeed, coupled positive and negative feedback mechanisms are likely essential for any robust, switch-like decision executed by biological circuits ([@bib61]). A full understanding of CO control will clearly require identification of the substrates of the ZHP ligase family and the effects of their modification.

A single crossover site could be selected, and other sites deselected, via a 'trigger wave' that moves rapidly through the SC from an initial site of stochastic CO designation and inhibits selection of nearby recombination intermediates ([Figure 8A](#fig8){ref-type="fig"}). However, such a mechanism cannot easily be reconciled with observations that pro-crossover factors, including Zip3, accumulate at recombination intermediates even prior to completion of synapsis in budding yeast, and likely in other organisms. Alternatively, coupled positive and negative regulation may give rise to a periodic standing wave, or Turing pattern ([@bib80]), of CO designation potential along each chromosome. This type of patterning requires interaction between two diffusible activities: an activating activity -- or 'morphogen,' to use Turing's term -- that acts locally and shows autocatalytic or cooperative behavior, and an inhibitory activity that acts over a greater distance. This type of pattern has intrinsic periodicity that depends on the activities and diffusion rates of the activator and inhibitor. Such a pattern could thus be established prior to full SC assembly, in which case designation of the first CO site would spatially fix one node of the pattern ([Figure 8A](#fig8){ref-type="fig"}). A Turing patterning mechanism is also consistent with evidence presented here and in previous studies that stabilization of recombination intermediates and CO patterning are tightly coupled. Evidence that mammalian RNF212 and Arabidopsis HEI10 act as dosage-sensitive modulators of recombination rates ([@bib63]; [@bib67]; [@bib94]) is compatible with either a temporally-dependent or standing wave model, since an increase or decrease in these activities could alter either the rate of signal propagation or the frequency of a waveform along paired chromosomes.

While the SC is an unusual, liquid crystalline material, liquid-liquid phase separation (LLPS) has been implicated in subcellular compartmentalization of diverse signaling mechanisms ([@bib6]). By diffusing and interacting within a spatially confined liquid compartment, biochemical signals could potentially establish a variety of periodic, Turing-type patterns within cells. Analogously, diffusion of signaling molecules within cell membranes can create two-dimensional patterns, which have been proposed to orchestrate polarity decisions ([@bib22]), as well as more elaborate patterning such as hexagonal arrays of stereocilia ([@bib29]).

Intriguingly, the ZHP proteins and their homologs are very similar to TRIM E3 ligases (tripartite motif: RING, B-box, coiled-coil domain), a very large family of enzymes with diverse cellular roles. The functions of most TRIM ligases are unknown, but like the ZHP proteins, they often form homo- or heterodimers, and many of these proteins appear to localize to cellular compartments, including globular nuclear and cytoplasmic bodies, or to filamentous structures such as microtubules ([@bib64]; [@bib66]). Thus, we speculate that compartmentalized regulatory mechanisms with similarities to the circuitry illuminated here may control other spatially-patterned activities within cells.

Conservation and divergence of the Zip3/ZHP protein family {#s3-2}
----------------------------------------------------------

RING finger proteins homologous to the ZHP family play important roles in CO formation in diverse eukaryotes ([@bib1]; [@bib2]; [@bib11]; [@bib23]; [@bib38]; [@bib63]; [@bib65]; [@bib67]; [@bib83]; [@bib85]; [@bib91]). Interestingly, the number of these proteins varies among organisms. The cytological distributions and apparent functions of ZHP-3/4 and ZHP-1/2 are very similar to those reported for the mammalian recombination regulators RNF212 and HEI10, respectively. Like ZHP-3/4, mouse RNF212 is required to stabilize recombination intermediates ([@bib67]), while HEI10, like ZHP-1/2, is required to limit the number of RNF212/MutSγ-positive foci along chromosomes and for robust CO maturation ([@bib63]). Most ZHP homologs also contain predicted coiled-coil domains and localize to the central region of the SC, including Zip3 in budding yeast, which forms foci along chromosomes but localizes throughout polycomplexes. A notable exception is a recently identified homolog required for crossovers in the ciliate *Tetrahymena thermophila*. This protein lacks a coiled-coil domain, likely related to the fact that this organism lacks SCs ([@bib75]).

HEI10 in *Sordaria* and *Arabidopsis*, and Zip3 in budding yeast, may be bifunctional proteins with roles similar to both ZHP-1/2 and ZHP-3/4, as suggested by their localization to CO sites and the apparent absence of RNF212 in these clades ([@bib1]; [@bib11]; [@bib14]). We speculate that they could play dual roles by partnering with multiple E2 conjugating enzymes, or perhaps with distinct substrate-recognition factors.

In mammals, RNF212 and HEI10 are thought to mediate opposing pro- and anti-crossover activities through SUMOylation and SUMO-dependent ubiquitylation, respectively ([@bib63]; [@bib65]; [@bib67]); a similar 'SUMO-ubiquitin switch' has been proposed based on findings in Sordaria ([@bib14]). In budding yeast, Sordaria, and mice, SUMOylation is essential for SC assembly, and thus for CO regulation ([@bib14]; [@bib27]; [@bib37]; [@bib39]; [@bib42]; [@bib65]; [@bib82]). In *C. elegans* we do not detect SUMO cytologically either along the SC or at CO sites, even with highly sensitive tools such as epitope-tagged SUMO transgenes ([@bib59]; data not shown). Further, genetic analysis has indicated that SMO-1 (SUMO) and its E2 conjugating enzyme UBC-9 are dispensable for synapsis and CO control in *C. elegans*, although they play key roles downstream of COs to mediate meiotic chromosome segregation in oocytes ([@bib7]; [@bib60]). Taken together, we favor the idea that each pair of ZHP proteins acts as a ubiquitin ligase, like the 'lion's share' of RING finger proteins ([@bib17]).

Our analysis also reveals that the *C. elegans* ZHP proteins likely function as heterodimers, or perhaps as higher order oligomers. It will be interesting to determine whether ZHP homologs in other organisms also have obligate partners, or perhaps homooligomerize, since this knowledge may help to illuminate their in vivo activities and substrates.

Regulation of sister chromatid cohesion by the ZHP family {#s3-3}
---------------------------------------------------------

In addition to their roles in CO control, the ZHP family also link COs to chromosome remodeling, which enables the stepwise release of cohesion during the MI and MII divisions ([Figure 8](#fig8){ref-type="fig"}). Specifically, we find that CO designation results in enrichment of ZHP-1/2 along one chromosome arm, which in turn promotes concentration of PLK-2 within this domain, asymmetric disassembly of the SC, and spatial regulation of cohesin function.

It is not clear whether sister chromatid cohesion during meiosis is regulated in the same fashion in other organisms. In budding and fission yeasts, Drosophila, diverse plants, and mammals, cohesion near centromeres is specifically retained during the first division ([@bib18]). Cohesin complexes containing the meiosis-specific kleisin Rec8 are enriched in pericentromeric heterochromatin and sometimes at centromere cores, and Shugoshin/MEI-S332, a Rec8-specific protective factor, is also recruited to these regions. In principle, programmed release of cohesion along arms and its retention near centromeres could suffice to allow homologs to segregate in MI while maintaining a link between sisters until MII. However, experimental evidence from several organisms indicates that CO formation leads to a local disruption of cohesion, which can predispose chromosomes to missegregate when COs occur close to centromeres ([@bib8]). In light of other similarities between ZHP-1/2 and HEI10, this raises the possibility that HEI10 may also influence sister chromatid cohesion, perhaps via spatial control of Polo-like kinases, which promote release of cohesion in mitosis and meiosis ([@bib4]). If so, HEI10 activity may directly impact chromosome missegregation in human oocytes, which has been attributed to compromised cohesion, and also -- very recently -- to inefficient CO maturation ([@bib84]), another process that involves HEI10.

Materials and methods {#s4}
=====================

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\                                  Designation                                                                                                                                Source or reference                                                                       Identifiers                                                                                           Additional\
  or resource                                                                                                                                                                                                                                                                                                                                                                                         information
  -------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------- -------------------------
  Gene (*Caenorhabditis elegans*)                          *zhp-1*                                                                                                                                    WormBase/This paper                                                                       WormBase ID: F55A12.10; WBGene00018867                                                                

  Gene (*Caenorhabditis elegans*)                          *zhp-2*                                                                                                                                    WormBase/This paper                                                                       WormBase ID: D1081.9; WBGene00008387                                                                  

  Gene (*Caenorhabditis elegans*)                          *zhp-3*                                                                                                                                    WormBase/([@bib30]) PMID: 15340062                                                        WormBase ID: K02B12.8b; WBGene00006976                                                                

  Gene (*Caenorhabditis elegans*)                          *zhp-4*                                                                                                                                    WormBase/This paper                                                                       WormBase ID: Y39B6A.16; WBGene00012678                                                                

  Strain, strain background (*Saccharomyces cerevisiae*)   *S. cerevisiae*: MaV203                                                                                                                    Invitrogen, Thermo Fisher Scientific, Waltham, MA                                         Cat\#11445012                                                                                         

  Strain, strain background (*Caenorhabditis elegans*)     For *C. elegans* allele and strain information, see [Supplementary file 1](#supp1){ref-type="supplementary-material"}, Tables S2 and S4.   This paper                                                                                N/A                                                                                                   

   Genetic reagent                                         For CRISPR/Cas9 reagents, see sequence-based reagent and peptide, recombinant protein.                                                     This paper                                                                                N/A                                                                                                   

  Antibody                                                 Rabbit polyclonal anti-SYP-1                                                                                                               ([@bib45]) PMID: 12231631                                                                 N/A                                                                                                   (1:500 IF)

  Antibody                                                 Rabbit polyclonal anti-SYP-2                                                                                                               ([@bib12]) PMID: 12967565                                                                 N/A                                                                                                   (1:500 IF)

  Antibody                                                 Rabbit polyclonal anti-HTP-1                                                                                                               ([@bib48]) PMID: 18923085                                                                 N/A                                                                                                   (1:500 IF)

  Antibody                                                 Rabbit polyclonal anti-RAD-51                                                                                                              \                                                                                         Cat\#29480002                                                                                         (1:5,000 IF)
                                                                                                                                                                                                      Millipore Sigma, St. Louis, MO                                                                                                                                                                  

  Antibody                                                 Rabbit polyclonal anti-pHIM-8/ZIMs                                                                                                         ([@bib35]) PMID: 26506311                                                                 N/A                                                                                                   (1:500 IF)

  Antibody                                                 Rabbit polyclonal anti-ZHP-3                                                                                                               ModENCODE/SDIX; ([@bib68]) PMID: 28045371                                                 Cat\#SDQ3956                                                                                          (1:5,000 IF)

  Antibody                                                 Rabbit polyclonal anti-MSH-5                                                                                                               ModENCODE/SDIX                                                                            Cat\#SDQ2376                                                                                          (1:5,000 IF)

  Antibody                                                 Rabbit polyclonal anti-REC-8                                                                                                               ModENCODE/SDIX                                                                            Cat\#SDQ0802                                                                                          (1:5,000 IF)

  Antibody                                                 Rabbit polyclonal anti-COH-3                                                                                                               ModENCODE/SDIX                                                                            Cat\#SDQ3972                                                                                          (1:5,000 IF)

  Antibody                                                 Rat polyclonal anti-HIM-8                                                                                                                  ([@bib62]) PMID: 16360035                                                                 N/A                                                                                                   (1:500 IF)

  Antibody                                                 Goat polyclonal anti-SYP-1                                                                                                                 ([@bib24]) PMID: 22018922                                                                 N/A                                                                                                   (1:300 IF)

  Antibody                                                 Chicken polyclonal anti-HTP-3                                                                                                              ([@bib46]) PMID: 16360034                                                                 N/A                                                                                                   (1:500 IF)

  Antibody                                                 Guinea pig polyclonal\                                                                                                                     ([@bib46]) PMID: 16360034                                                                 N/A                                                                                                   (1:500 IF) (1:1,500 WB)
                                                           anti-HTP-3                                                                                                                                                                                                                                                                                                                                 

  Antibody                                                 Guinea pig polyclonal\                                                                                                                     ([@bib24]) PMID: 22018922                                                                 N/A                                                                                                   (1:100 IF)
                                                           anti-PLK-2                                                                                                                                                                                                                                                                                                                                 

  Antibody                                                 Rabbit polyclonal\                                                                                                                         Millipore Sigma                                                                           Cat\#V8137; RRID:[AB_261889](https://scicrunch.org/resolver/AB_261889)                                (1:250 IF)
                                                           anti-V5                                                                                                                                                                                                                                                                                                                                    

  Antibody                                                 Mouse monoclonal\                                                                                                                          Thermo Fisher Scientific                                                                  Cat\#R960-25; RRID:[AB_2556564](https://scicrunch.org/resolver/AB_2556564)                            (1:500 IF) (1:1,000 WB)
                                                           anti-V5                                                                                                                                                                                                                                                                                                                                    

  Antibody                                                 Mouse monoclonal anti-FLAG M2                                                                                                              Millipore Sigma                                                                           Cat\#F1804; RRID:[AB_262044](https://scicrunch.org/resolver/AB_262044)                                (1:500 IF) (1:1,000 WB)

  Antibody                                                 Mouse monoclonal anti-HA, clone 2--2.2.14                                                                                                  Thermo Fisher Scientific                                                                  Cat\#26183; RRID:[AB_10978021](https://scicrunch.org/resolver/AB_10978021)                            (1:400 IF) (1:1,000 WB)

  Antibody                                                 Mouse monoclonal\                                                                                                                          Millipore Sigma                                                                           Cat\#11814460001; RRID:[AB_390913](https://scicrunch.org/resolver/AB_390913)                          (1:500 IF) (1:1,000 WB)
                                                           anti-GFP                                                                                                                                                                                                                                                                                                                                   

  Antibody                                                 Mouse monoclonal anti-α-tubulin, clone DM1A                                                                                                Millipore Sigma                                                                           Cat\#05--829; RRID:[AB_310035](https://scicrunch.org/resolver/AB_310035)                              (1:5,000 WB)

  \                                                        *P~eft-3~::*AID::GFP*::unc-54* 3'UTR                                                                                                       ([@bib93]) PMID: 26552885; Addgene                                                        pLZ29; Addgene plasmid \#71719                                                                        
  Recombinant DNA reagent                                                                                                                                                                                                                                                                                                                                                                             

  Recombinant DNA reagent                                  cDNA *zhp-1*                                                                                                                               WormBase                                                                                  WormBase ID: F55A12.10; WBGene00018867                                                                

  Recombinant DNA reagent                                  cDNA *zhp-2*                                                                                                                               WormBase                                                                                  WormBase ID: D1081.9; WBGene00008387                                                                  

  Recombinant DNA reagent                                  cDNA *zhp-3*                                                                                                                               WormBase                                                                                  WormBase ID: K02B12.8b; WBGene00006976                                                                

  Recombinant DNA reagent                                  cDNA *zhp-4*                                                                                                                               WormBase (codon-optimized byIntegrated DNA Technologies to facilitate gBlock synthesis)   WormBase ID: Y39B6A.16; WBGene00012678                                                                

  Recombinant DNA reagent                                  Plasmid: pDEST32-*zhp-1*-V5                                                                                                                This paper                                                                                N/A                                                                                                   

  Recombinant DNA reagent                                  Plasmid: pDEST32-*zhp-2*-3xFLAG                                                                                                            This paper                                                                                N/A                                                                                                   

  Recombinant DNA reagent                                  Plasmid: pDEST32-*zhp-3*-3xFLAG                                                                                                            This paper                                                                                N/A                                                                                                   

  Recombinant DNA reagent                                  Plasmid: pDEST32-*zhp-4*-HA                                                                                                                This paper                                                                                N/A                                                                                                   

  Recombinant DNA reagent                                  Plasmid: pDEST22-*zhp-1*-V5                                                                                                                This paper                                                                                N/A                                                                                                   

  Recombinant DNA reagent                                  Plasmid: pDEST22-*zhp-2*-3xFLAG                                                                                                            This paper                                                                                N/A                                                                                                   

  Recombinant DNA reagent                                  Plasmid: pDEST22-*zhp-3*-3xFLAG                                                                                                            This paper                                                                                N/A                                                                                                   

  Recombinant DNA reagent                                  Plasmid: pDEST22-*zhp-4*-HA                                                                                                                This paper                                                                                N/A                                                                                                   

  Sequence-based reagent                                   FISH probe to the right arm of Chromosome V (5S rDNA)                                                                                      ([@bib15]) PMID: 9708740                                                                  N/A                                                                                                   

  Sequence-based reagent                                   FISH Probe to the right arm of X Chromosome                                                                                                ([@bib62]) PMID: 16360035                                                                 N/A                                                                                                   

  Sequence-based reagent                                   CRISPR tracrRNA                                                                                                                            Integrated DNA Technologies, Skokie, IL                                                   Cat\#1072534                                                                                          

  Sequence-based reagent                                   For crRNAs, repair templates and genotyping primers, see [Supplementary file 1](#supp1){ref-type="supplementary-material"},Table S3        This paper                                                                                N/A                                                                                                   

  Peptide, recombinant protein                             *S. pyogenes* Cas9-NLS purified protein                                                                                                    QB3 MacroLab at UC Berkeley                                                               N/A                                                                                                   

  Chemical compound, drug                                  Auxin: 1H-Indole-3-acetic acid                                                                                                             Thermo Fisher Scientific, Waltham, MA                                                     Cat\#122160250; CAS:87-51-4                                                                           

  Chemical compound, drug                                  NuSieve 3:1 agarose                                                                                                                        Lonza, Walkersville, MD                                                                   Cat\#50090                                                                                            

  Chemical compound, drug                                  Nuclease-Free Duplex Buffer                                                                                                                Integrated DNA Technologies                                                               Cat\#11-01-03-01                                                                                      

  Commercial assay or kit                                  SuperSignal West Femto Maximum Sensitivity Substrate kit                                                                                   Thermo Fisher Scientific                                                                  Cat \#34095                                                                                           

  Software, algorithm                                      SoftWorx package                                                                                                                           Applied Precision; GE Healthcare Bio- Sciences, Pittsburgh, PA                            <http://www.gelifesciences.com/webapp/wcs/stores/servlet/productById/en/GELifeSciences-us/29065728>   

   Software, algorithm                                     ImageJ                                                                                                                                     NIH                                                                                       <https://imagej.nih.gov/ij/>                                                                          

   Software, algorithm                                     Adobe Photoshop CC 2014                                                                                                                    Adobe Systems, San Jose, CA                                                               <http://www.adobe.com/products/photoshop.html>                                                        

   Software, algorithm                                     T-COFFEE                                                                                                                                   Swiss Institute of Bioinformatics; ([@bib54]) PMID:10964570                               <http://tcoffee.vital-it.ch/apps/tcoffee/index.html>                                                  

  Software, algorithm                                      IBS_1.0.1                                                                                                                                  ([@bib43]) PMID: 26069263                                                                 <http://ibs.biocuckoo.org/download.php>                                                               

  Software, algorithm                                      Clustal Omega                                                                                                                              EMBL-EBI                                                                                  <http://www.clustal.org/omega/>                                                                       

  Software, algorithm                                      Graphpad Prism                                                                                                                             Graphpad Software, Inc., La Jolla, CA                                                     <http://www.graphpad.com/>                                                                            

  Software, algorithm                                      MSG software package                                                                                                                       ([@bib3]) PMID: 21233398                                                                  <https://github.com/JaneliaSciComp/msg>                                                               
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Generation of transgenic worm strains {#s4-1}
-------------------------------------

All *C. elegans* strains were maintained on nematode growth medium (NGM) plates seeded with OP50 bacteria at 20°C. All epitope-tagged genes used in this study were fully functional, as indicated by their ability to support normal meiosis ([Supplementary file 1](#supp1){ref-type="supplementary-material"}, Table S1). New alleles and their detailed information are listed in [Supplementary file 1](#supp1){ref-type="supplementary-material"}, Tables S2 and S3. Unless otherwise indicated, new alleles in this study were generated by genome editing, by injection of Cas9-gRNA RNP complexes, using *dpy-10* Co-CRISPR to enrich for edited progeny ([@bib5]; [@bib57]). Cas9-NLS protein was produced by the MacroLab at UC Berkeley. The protein was complexed *in vitro* with equimolar quantities of duplexed tracrRNA and target-specific crRNAs, purchased from Integrated DNA Technologies (IDT). Repair templates were single- or double-stranded amplicons generated by asymmetric or standard PCR, respectively, or Ultramer oligonucleotides purchased from IDT. Each 10 µl of injection mixture contained: 16 µM \[Cas9 protein + gRNA\] (target gene + *dpy-10*), plus 0.16--2 µM long and/or 6 µM oligonucleotide repair templates. In cases where Unc worms were injected (*e.g.,* to tag *zhp* genes in a *syp-1(me17)*/*nT1* strain), plasmids encoding green fluorescent reporter proteins were co-injected to enrich for edited progeny.

Injected animals were transferred to individual plates and incubated at 20 ˚C. After 4 days, F1 Rol or Dpy progeny (*dpy-10* heterozygotes or homozygotes, respectively) from 'jackpot' broods containing multiple Rol/Dpy animals were picked to individual plates, allowed to produce self-progeny, then lysed and screened by PCR.

Disruption of the *zhp-1* gene was accomplished by inserting the sequence TAAGCTCGAG after the 6^th^ codon, introducing a stop codon, a frameshift, and an Xho I restriction site. Three independent alleles of the same sequence were generated: *ie43* and *ie44* in the N2 strain background, and *ie46* in the CB4856 strain. The *zhp-2* gene was similarly disrupted by insertion of TAATAATTAATTAG after the 7^th^ codon, resulting in multiple stop codons and a frameshift.

See [Supplementary file 1](#supp1){ref-type="supplementary-material"}, Table S4 for a full list of strains used. Unless otherwise indicated, young adults were used for both immunofluorescence and Western blotting assays. Synchronized young adults were obtained by picking L4 larvae and culturing them for 20--24 hr at 20°C.

Auxin-mediated protein depletion {#s4-2}
--------------------------------

To deplete AID-tagged proteins in a strain expressing the *AtTIR1* transgene, animals were treated with auxin (indole acetic acid, IAA) as previously described ([@bib93]). Briefly, NGM agar was supplemented with 1 mM IAA just before pouring plates. *E. coli* OP50 bacteria cultures were concentrated and spread on plates, which were allowed to dry before transferring *C. elegans* onto the plates.

We note that several major advantages of the AID system have facilitated our study of these proteins in meiosis: (i) this approach enables temporal control and germline-specific degradation of proteins; (ii) complex strains that combine various mutations and epitope-tagged alleles can be constructed far more easily, since balancer chromosomes are not required to maintain conditional alleles of genes essential for reproduction. Additionally, control experiments can be performed using the same strains without auxin treatment, and partial protein depletion can be achieved by titrating auxin concentrations.

Viability and fertility {#s4-3}
-----------------------

To quantify brood size and males among self-progeny, L4 hermaphrodites were picked onto individual plates and transferred to new plates daily over 4 days. Eggs were counted every day. Viable progeny and males were counted when the F1 reached the L4 or adult stages. To analyze viability and fertility in the presence of auxin, L1s were transferred onto auxin plates and grown to the L4 stage. Hermaphrodites were then transferred onto fresh auxin plates, transferred daily over 4 days, and progeny were scored as described above.

Recombination mapping by whole-genome sequencing {#s4-4}
------------------------------------------------

The *zhp-1* gene was disrupted by CRISPR/Cas9-based genome editing in both the N2 Bristol and CB4856 Hawaiian strain backgrounds, as described above (allele designations: *ie43* and *ie46*, respectively). By crossing animals carrying these mutations, we generated N2/CB4856 hybrids lacking *zhp-1.* To map meiotic COs that occurred during oogenesis in these animals, hybrid hermaphrodites were backcrossed to (*zhp-1*^+^) CB4856 males. Hermaphrodite progeny from this cross were picked to individual 60 mm plates and allowed to produce self-progeny until the plates were starved. Genomic DNA was extracted from these pools of progeny using Gentra Puregene Tissue Kit (QIAGEN, Hilden, Germany), and quantified by Qubit (Invitrogen). Sequencing libraries were constructed in the Functional Genomics Lab (FGL), a QB3-Berkeley Core Research Facility at UC Berkeley. DNA was Fragmented with an S220 Focused-Ultrasonicator (Covaris, Woburn, MA), then cleaned and concentrated with the MinElute PCR Purification kit (QIAGEN). Library preparation was done on an Apollo 324 with PrepX ILM 32i DNA Library Kits (WaferGen Biosystems, Fremont, CA). 9 cycles of PCR amplification were used. The average insert size of libraries was 380 bp. 150PE sequencing at approximately 9x coverage was carried out on an Illumina Hiseq 2500 by the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley. Two libraries for each of the parental strains (N2 and CB4856) were prepared in parallel, sequenced at 30x coverage, and aligned to the reference genome sequences available through Wormbase or ([@bib78]). To map COs, the data were analyzed using the MSG software package (<https://github.com/JaneliaSciComp/msg>) ([@bib3]).

Yeast two-hybrid analysis {#s4-5}
-------------------------

To test for interactions among the ZHP proteins using the yeast two-hybrid system, coding sequences for ZHP-1-V5, ZHP-2-3xFLAG, ZHP-3-3xFLAG and ZHP-4-HA were synthesized as gBlocks by Integrated DNA Technologies (IDT). Epitope tags were appended to the protein sequences so that expression in yeast could be monitored. The coding sequence for ZHP-4 was codon-optimized by IDT to facilitate gBlock synthesis and expression in yeast. Each of these sequences was fused to both the GAL4 DNA binding domain and the GAL4 activation domain by insertion into pDEST32 and pDEST22, respectively, using the Gateway cloning system, following the manufacturer's instructions (Invitrogen).

All possible pairwise combinations of the four ZHP proteins, including potential homodimers, were tested using the ProQuest^TM^ Two-Hybrid System (Invitrogen). Briefly, each pair of bait and prey plasmids was co-transformed into yeast strain MaV203 using standard LiAc-mediated transformation. To test for specific interactions, 2--4 independent clones of each strain were assayed for *HIS3*, *URA3* and *LacZ* induction. Negative and positive controls provided with the ProQuest^TM^ kit (Cat. Series 10835) were run in parallel.

Microscopy {#s4-6}
----------

Immunofluorescence experiments were performed as previously described ([@bib93]), except that samples were mounted in Prolong Diamond mounting medium with DAPI (Millipore Sigma). Primary antibodies were obtained from commercial sources or have been previously described, and were diluted as follows: Rabbit anti-SYP-1 \[1:500, ([@bib45]), Rabbit anti-SYP-2 \[1:500, ([@bib12]), Rabbit anti-HTP-1 \[1:500, ([@bib48]), Rabbit anti-RAD-51 (1:5,000, Novus Biologicals, \#29480002), Rabbit anti-pHIM-8/ZIMs \[1:500, ([@bib35]), Rabbit MSH-5 \[1:5,000, modENCODE/SDIX, \#SDQ2376, ([@bib88]), Rabbit anti-REC-8 (1:5,000, modENCODE/SDIX, \#SDQ0802), Rabbit anti-COH-3 (1:5,000, modENCODE/SDIX, \#SDQ3972), Guinea pig anti-PLK-2 \[1:100, ([@bib24]), Goat anti-SYP-1 \[1:300, ([@bib24]), Chicken anti-HTP-3 \[1:500, ([@bib46]), Rabbit anti-ZHP-3 \[1:5,000, modENCODE/SDIX, \#SDQ3956, ([@bib68]), Rat anti-HIM-8 \[1:500, ([@bib62]), Mouse anti-FLAG (1:500, Sigma, \#F1804), Mouse anti-HA (1:400, Thermo Fisher, \#26183), Mouse anti-V5 (1:500, Thermo Fisher, \#R960-25), Rabbit anti-V5 (1:250, Millipore Sigma, \#V8137), Mouse anti-GFP (1:500, Millipore Sigma, \#11814460001). Secondary antibodies labeled with Alexa 488, Cy3 or Cy5 were purchased from Jackson ImmunoResearch (West Grove, PA) and used at 1:500.

Chromosomal *in situ* hybridization was performed as previously described ([@bib15]) with modifications. Briefly, worms were dissected and fixed essentially according to the immunofluorescence protocol described above. Fixed worm gonads were then washed with 2xSSCT and incubated in 50% formamide/2xSSCT overnight at 37°C. Tissue and probes were denatured at 91°C for 2 min, then hybridized overnight at 37 ˚C. Hybridized gonads were then washed and stained with DAPI. Two chromosome-specific probes were used: an oligonucleotide targeting a short repetitive sequence on the X chromosome ([@bib41]; [@bib62]) and the 5S rDNA repeat on the right arm of chromosome V ([@bib15]). FISH probes were labeled with aminoallyl-dUTP (Millipore Sigma) by terminal transferase-mediated 3' end-labeling, followed by conjugation to Alexa 488-NHS-ester (Thermo Fisher Scientific) or Cy3-NHS-ester (Themo Fisher Scientific), as previously described ([@bib16])

All images were acquired as z-stacks through 8 µm depth at intervals of 0.2 µm using a DeltaVision Elite microscope (GE) with a 100x, 1.4 N.A. oil-immersion objective. Iterative 3D deconvolution, image projection and colorization were carried out using the SoftWoRx package and Adobe Photoshop CC 2014.

Western blotting {#s4-7}
----------------

Adult worms were picked into SDS sample buffer and lysed by boiling for 30 min, a single freeze/thaw cycle in liquid nitrogen, and occasionally vortexing. Whole worm lysates were separated on 4--12% polyacrylamide gradient gels and blotted with indicated antibodies: Mouse anti-GFP (1:1,000, Millipore Sigma, \#11814460001), Mouse anti-FLAG (1:1,000, Millipore Sigma, \#F1804), Mouse anti-HA (1:1,000, Thermo Fisher, \#26183), Mouse anti-V5 (1:1,000, Thermo Fisher, \#R960-25), Mouse anti-α-tubulin (1:5,000, Millipore Sigma, \#05--829), Guinea pig anti-HTP-3 \[1:1,500, ([@bib46]). HRP-conjugated secondary antibodies (Jackson Immunoresearch \#115-035-068) and SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Fisher, \#34095) were used for detection.

To quantify Western blots, TIF images were collected for each blot using a Chemidoc system (Bio-Rad, Hercules, CA). Integrated intensities for relevant bands were then calculated using ImageJ. To normalize for sample loading, the indicated band intensity was divided by the corresponding α-tubulin or HTP-3 band intensity. Each normalized band intensity is expressed as the percentage of the intensity at t = 0 or in a control sample.

Quantification and statistical analysis {#s4-8}
---------------------------------------

Quantification methods and statistical parameters are indicated in the legend of each figure, including error calculations (SD or SEM), *n* values, statistical tests, and p-values. p\<0.05 was considered to be significant.
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###### This file includes four tables (Table S1-S4).

Table S1 reports analysis of the progeny produced by animals expressing epitope-tagged proteins described in this work. In all cases, animals homozygous for these epitope-tagged alleles show no reduction in embryonic viability or increase in male production, indicating that the epitope tags used to detect various proteins do not impair their meiotic functions. Table S2 provides a list of all new alleles generated in this work, with details about the genome editing methods used to introduce epitope tags or mutations. Table S3 includes the sequences of RNA and DNA sequences used for genome editing, including synthetic CRISPR RNAs (crRNAs), repair templates, and DNA primers used for detecting or genotyping these mutations. In cases where restriction digests were used for genotyping, fragment sizes for wild-type and mutant alleles are also provided. Table S4 lists new worm strains constructed in the course of this work, as well as previously referenced strains.
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Bernard

Reviewing Editor

Institute of Human Genetics, CNRS UPR 1142

France

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"A compartmentalized, self-extinguishing signaling network mediates crossover control in meiosis\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Bernard de Massy as Reviewing Editor and Jessica Tyler as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The authors have identified three novel members of the ZHP-3 family (named ZHP-1, -2 and -4) in *C. elegans*, in addition to the previously characterized ZHP-3. The authors analyzed the localization of these proteins, their interactions, the consequence of their depletion (using an AID driven degradation strategy) and their functional relationships with other functions involved in CO formation.

Altogether, this manuscript reports a novel and important analysis with the evidence for two distinct activities, one mediated by ZHP-3/4 essential for CO designation and one by ZHP-1/2 limiting ZHP-3/4 activity and promoting chromosome remodeling. Interestingly, ZHP-1/2 are the earliest known factors to localize asymmetrically on chromosome arms after COSA-1 foci formation. The DSB-2 depletion and irradiation experiments are notable advances and lend further support to the idea that recombination sites compete for limiting CO components and/or ZHPs stabilize such a factor. DSB-2 depletion experiments also nicely clarify the relationships between excess recombination sites, ZHP-1/-2, CO designation and ZHP-3/-4 dynamics. This is a very interesting paper that provides roles for three new regulators of meiotic recombination and ties in nicely with recent analyses of RING protein in mice (RNF212 and HEI10), Sordaria and Arabidopsis indicating conserved regulatory pathways.

The data is convincing, and experiments carefully performed. However, the presentation could be improved. Overall the manuscript needs substantial revision.

Several cytological analyses require better presentation and/or additional quantification. Importantly, the authors should revise several of their interpretations and conclusions which are overstated. This also applies to the title which should relate to the experimental evidence not to hypotheses about a proposed self-extinguishing network. It is essential that they integrate and refer to in their interpretations observations from other related studies (see details below). It would also be helpful to clarify the presentation of some analysis due to the complexity of the different effects or markers that are analyzed. It is not clear why the authors presented effects on bivalents and chiasmata first and why they did not start by reporting synapsis, recombination foci...and then chiasmata.

Essential revisions:

Introduction. With respect to mobility of SC proteins, cite pertinent studies by MacQueen (https://www.ncbi.nlm.nih.gov/pubmed/23071451), Villeneuve (https://www.ncbi.nlm.nih.gov/pubmed/28339470) and Colaiacovo (https://www.ncbi.nlm.nih.gov/pubmed/28346135) labs.

Results section. Provide citations for RNF212 and HEI10.

Subsection "Conservation of crossover control mechanisms". Please note that similar positive-feedback loop ideas have been proposed by others (Villeneuve and Hunter labs) and should be cited.

Subsection "Conservation of crossover control mechanisms". Cite haplo-insufficiency phenotypes of Rnf212 and Hei10 mice as evidence for roles in crossover assurance.

1\) Basic controls: Validation of the signal detected with the antibodies (negative control?).

Validation of the function of the fusion proteins. Are the worms used for cytology homozygous? I assume, Table S1 shows that the transgene are functional. This should be explicitly mentioned.

2\) Subsection "ZHP proteins exhibit two distinct patterns of dynamic localization during meiosis". As this is the first description of ZHP-4, those foci should be quantified as well as their colocalization with COSA-1.

3\) Results section. The ZHP signals in the syp-1 mutant should be clarified (late pachytene bright foci).

The authors conclude that ZHP proteins are not associated with chromosomes in syp-1 mutant. This should be demonstrated, which implies that the localization of the polycomplexes with respect to chromosomes should be determined. Several nuclei seem to have 4 foci. Do they colocalize with DSB proteins?

In the syp-1/+ strain, doublets of ZHP-3 are often seen at late pachytene (Figure 1---figure supplement 2C). Is this a reproducible observation?

4\) Subsection "Association of ZHPs with meiotic chromosomes depends on synaptonemal complexes". The authors should define what they mean by CO designation, how it is monitored and what is the basis for assuming that COSA-1 and MSH-5 are required for CO designation.

5\) Subsection "ZHPs act as two heterodimeric complexes". Head of section should be revised. The data presented does not show that the complexes are heterodimeric.

6\) Subsection "ZHP-3/4 are essential for CO designation, while ZHP-1/2 limit ZHP-3/4 activity and promote CO maturation". The dim COSA-1 foci observed in zhp-1/2 mutants should be clarified. This is an essential point since the authors conclude based on this observation that ZHPs limit CO. However, the Spo11 dependency does not tell whether these foci are DSB repair sites. Co-staining with DSB repair protein should be tested (RAD-51, RPA). These foci are obviously not converted into CO. MSH5 foci (Figure 4---figure supplement 1) appear substantially brighter in the zhp-1/2 mutants. Is this correct or a matter of image adjustment/exposure? Do they vary in size/brightness? The increase from mid to late pachytene is not visible on Figure 4---figure supplement 1. Their numbers also appear to be higher than previous various estimates of DSB events.

The authors may consider the possibility that MSH-5 foci are transient or destabilized in zhp-3 (4) mutant.

7\) The impact of ZHP-1/2 on axis remodeling is not convincing. The statement that HTP-1 and SYP-1 remain colocalized in zhp-1 mutant (Figure 6---figure supplement 1B) is not seen on the figure (Figure 6---figure supplement 1B) where only a fraction of the proteins colocalizes in nucleus \#2.

The authors conclude that in the absence of ZHP-1/2, SC remodeling on axis is defective (with persistence on both short on long arms), but this is not the case in the context of DSB-2. Thus, there is a ZHP-1/2 independent remodeling of SC proteins? Please clarify and revise the statement \"ZHP-1/2 mediate chromosome remodeling\".

8\) Subsection "Conservation of crossover control mechanisms". Clarify what is meant by \"Evidence presented here\[...\]\": Which data indicate that ZHP activity is responsible for signal propagation in crossover interference? How does this idea explain the dosage sensitivity of RNF212/HEI10?

9\) Figure 1---figure supplement 2: Western blots: why normalizing by HTP-3 if the level of this protein is not the same in wt and syp1? Tubulin should be used. Then revise subsection "Association of ZHPs with meiotic chromosomes depends on synaptonemal complexes" about the abundance of these proteins.

Provide statistical analysis of the differences in protein levels. Figure 1---figure supplement 2 legend: replace overestimates by underestimates or delete

10\) Subsection "ZHPs play essential roles in chiasma formation and chromosome segregation". It is argued you that zhp-1/2 are more viable than zhp-3, is it statistically significant?

11\) Figure 3---figure supplement 1G, H, I, J. For RAD-51 foci, present scatter graphs showing the 4 data points.

12\) Figure 3 statistical tests and P values should be provided for the distributions in A-D.

13\) Figure 5 panel D, Figure 5---figure supplement 1 Panel C. COSA-1 foci should be quantified

14\) Subsection "Conservation of crossover control mechanisms". SUMO or ubiquitin ligase activities of these proteins have not been established. This statement should be removed.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for submitting your article \"A compartmentalized signaling network mediates crossover control in meiosis\" for consideration by *eLife*. Your article has been reviewed and the evaluation has been overseen by a Reviewing Editor and Jessica Tyler as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

We thank the authors for the revised version of the manuscript and their answers to referees' comments. This revised version provides now a convincing set of data and conclusions.

One important point that needs to be revised in accordance with *eLife* editorial policy is the Abstract. Although the Abstract can certainly highlight the general conclusion about the regulatory network, it must report the key experimental findings (ie the CO controls, designation and maturation, by Zhp-1/Zhp-2 and by Zhp-3 and Zhp-4, the compartmentalization and its asymmetry...).

In addition, several sentences of the abstract should be revised:

It should be acknowledged that one member, Zhp-3, was already identified.

The term \"stepwise segregation\" should be changed as it will be obscure for most readers.

The use of \"winners-takes-all\" is not specifically explanatory because one is left with the question of who wins and what does it take to win?

The evolutionary conservation is also not properly reported in this abstract since it was already supported by previous work in mammals, yeast and sordaria.

1\) In the main text, change the term « meiotic cohesion » which cannot be understood as such.

2\) Subsection "A family of meiotic RING finger proteins in *C. elegans"*, third paragraph. Three data not shown are referred to. Please show homology to mammalian RNF212 and to Hei10 and add the information in Figure 1---figure supplement 1.

3\) It would help if the authors emphasize that the compartment they refer to is a bivalent with its SC and thus conveys bivalent autonomous properties. This is mentioned in subsection "ZHP-1/2 mediate chromosome remodeling in response to CO designation", but it could also be mentioned subsection "Compartmentalization of CO regulation by the synaptonemal complex".

4\) In the Introduction, add \"likely\" heterodimeric to qualify the protein complexes.

5\) Introduction. Whether it is poorly understood is subjective, the authors should rather acknowledge what is known (work on RNF212 and HEI10) or not.

6\) Data of the quantification of Zhp-4 and Cosa foci should be provided to support the sentence" At late pachynema, all GFP-COSA-1 foci colocalize with ZHP-4 puncta in 100% of nuclei (n=450 nuclei, 11 rows of nuclei from 8 gonads were scored). 3F indicates 3xFLAG. Scale bars, 5μm." (Figure 1 legend).

7\) Ambiguity persists on the use of CO designation and maturation and the criteria used for monitoring this.

Subsection "ZHP proteins exhibit two distinct patterns of dynamic localization during meiosis": CO designation is thought to occur at mid pachytene

However, the criteria for CO designation is bright COSA-1 foci which are fully detected at late pachynema (It should be mentioned that the criteria for CO maturation is chiasma or genetic exchange). (Subsection "ZHP proteins exhibit two distinct patterns of dynamic localization during meiosis": Upon the appearance of GFP COSA-1 foci, which mark designated crossover sites).

The use of « robust » CO designation is also confusing (subsection "ZHP-3/4 are essential to stabilize CO intermediates, while ZHP-1/2 restrict pro-CO activities") because it is also used to relate to the brightness of COSA-1 foci (Subsection "ZHP-1/2 mediate chromosome remodeling in response to CO designation": COs were robustly marked by COSA-1).

In Zhp-1 mutant bright COSA-1 foci are absent but still some low level of CO is detected. I assume the authors want to suggest that CO designation is not completely abolished in Zhp-1 mutant (robust is also used to qualify interference and maturation).

10.7554/eLife.30789.031

Author response

> Summary:
>
> The authors have identified three novel members of the ZHP-3 family (named ZHP-1, -2 and -4) in C. elegans, in addition to the previously characterized ZHP-3. The authors analyzed the localization of these proteins, their interactions, the consequence of their depletion (using an AID driven degradation strategy) and their functional relationships with other functions involved in CO formation.
>
> Altogether, this manuscript reports a novel and important analysis with the evidence for two distinct activities, one mediated by ZHP-3/4 essential for CO designation and one by ZHP-1/2 limiting ZHP-3/4 activity and promoting chromosome remodeling. Interestingly, ZHP-1/2 are the earliest known factors to localize asymmetrically on chromosome arms after COSA-1 foci formation. The DSB-2 depletion and irradiation experiments are notable advances and lend further support to the idea that recombination sites compete for limiting CO components and/or ZHPs stabilize such a factor. DSB-2 depletion experiments also nicely clarify the relationships between excess recombination sites, ZHP-1/-2, CO designation and ZHP-3/-4 dynamics. This is a very interesting paper that provides roles for three new regulators of meiotic recombination and ties in nicely with recent analyses of RING protein in mice (RNF212 and HEI10), Sordaria and Arabidopsis indicating conserved regulatory pathways.
>
> The data is convincing, and experiments carefully performed. However, the presentation could be improved. Overall the manuscript needs substantial revision.

We thank the reviewers for their positive comments, and for the very detailed, constructive, and perceptive review. We address the individual comments below.

> Several cytological analyses require better presentation and/or additional quantification. Importantly, the authors should revise several of their interpretations and conclusions which are overstated. This also applies to the title which should relate to the experimental evidence not to hypotheses about a proposed self-extinguishing network.

Upon reflection, we agree with the reviewers that other interpretations of our data are equally viable, and we have extensively revised our Discussion section in response and have changed the title of the paper to focus on the compartmentalized nature of the signaling network. We also added additional quantification for several of our cytological analyses and revised some interpretations according the reviewers' suggestions and comments (see below for details).

> It is essential that they integrate and refer to in their interpretations observations from other related studies (see details below). It would also be helpful to clarify the presentation of some analysis due to the complexity of the different effects or markers that are analyzed. It is not clear why the authors presented effects on bivalents and chiasmata first and why they did not start by reporting synapsis, recombination foci...and then chiasmata.

We have modified the order of presentation, and feel that the current flow, in which the localization of the proteins is described, and their functions were then analyzed systematically, was the most straightforward presentation. In particular, we feel that the observation that chiasmata depend absolutely on ZHP-3/4 but only partially on ZHP-1/2 helps to contextualize and interpret some of the findings we describe subsequently regarding recombination intermediates.

> Essential revisions:
>
> Introduction. With respect to mobility of SC proteins, cite pertinent studies by MacQueen (https://www.ncbi.nlm.nih.gov/pubmed/23071451), Villeneuve (https://www.ncbi.nlm.nih.gov/pubmed/28339470) and Colaiacovo (https://www.ncbi.nlm.nih.gov/pubmed/28346135) labs.
>
> Results section. Provide citations for RNF212 and HEI10.
>
> Subsection "Conservation of crossover control mechanisms". Please note that similar positive-feedback loop ideas have been proposed by others (Villeneuve and Hunter labs) and should be cited.
>
> Subsection "Conservation of crossover control mechanisms". Cite haplo-insufficiency phenotypes of Rnf212 and Hei10 mice as evidence for roles in crossover assurance.

We thank the reviewers for this suggestion. We have added the suggested references (some of which were not published at the time of our initial submission) and related work from other groups in the new manuscript.

> 1\) Basic controls: Validation of the signal detected with the antibodies (negative control?).
>
> Validation of the function of the fusion proteins. Are the worms used for cytology homozygous? I assume, Table S1 shows that the transgene are functional. This should be explicitly mentioned.

We thank the reviewers for this suggestion. The antibodies used in this study have all been previously validated for specificity in *C. elegans* (appropriate references are cited in the Materials and methods section), with the possible exception of the well-characterized commercial anti-epitope antibodies used to detect tagged proteins. To address the reviewers' comments, we now include images demonstrating a lack of background staining with these anti-epitope antibodies in *C. elegans* germline tissue (Figure 1---figure supplement 2 and Figure 2---figure supplement 2A-B). We also state explicitly in the manuscript that all transgenes used in the study are fully functional, as documented quantitatively in Supplementary file 1. Except where otherwise stated, animals used for cytological analysis were homozygous for mutant or degron-tagged alleles. In all cases, the genotypes are specified in the text, figures, and/or figure legends.

> 2\) Subsection "ZHP proteins exhibit two distinct patterns of dynamic localization during meiosis". As this is the first description of ZHP-4, those foci should be quantified as well as their colocalization with COSA-1.

Quantification of immunofluorescent foci, particularly in whole-mount tissues, is inherently challenging and problematic. Differences in the affinity of antibodies or abundance of various proteins make it problematic to compare numbers of foci, since an unknown fraction of foci may be below the limit of detection. For example, we report here that we detect more MSH-5 foci than COSA-1 foci per nucleus in both wild-type and *zhp-1/2* mutants, but this likely reflects a difference in sensitivity rather than a *bona fide* difference in the frequency of their association with recombination intermediates. We have quantified foci in those cases where we felt it would be meaningful to compare between genotypes.

In response to the reviewers' specific request regarding ZHP-4 foci, we have now quantified the colocalization of ZHP-4 with COSA-1. We report that in 100% of wild-type oocytes, all GFP-COSA-1 foci at late pachytene colocalized with ZHP-4 puncta (11 row of nuclei from every 8 gonads were scored). We include this data in the revised manuscript. However, we feel quantification of ZHP-4 foci in early prophase would be a very difficult task and would not be informative.

> 3\) Results section. The ZHP signals in the syp-1 mutant should be clarified (late pachytene bright foci).
>
> The authors conclude that ZHP proteins are not associated with chromosomes in syp-1 mutant. This should be demonstrated, which implies that the localization of the polycomplexes with respect to chromosomes should be determined. Several nuclei seem to have 4 foci. Do they colocalize with DSB proteins?
>
> In the syp-1/+ strain, doublets of ZHP-3 are often seen at late pachytene (Figure 1---figure supplement 2C). Is this a reproducible observation?

We thank the reviewers for the question. We have now added statements to clarify that these foci of ZHP proteins do not colocalize with SYP proteins, and are thus not polycomplexes, but rather a distinct type of aggregate. We have also added images to show that ZHPs foci in *syp-1* mutants do not colocalize with recombination intermediates marked by RAD-51 (Figure 1---figure supplement 3D).

We have examined our 3D data stacks in detail and conclude that doublets of ZHP-3 staining are infrequently observed. Given that we did not observe nuclei at later stages showing more than 6 ZHP-3 foci, we do not think it likely that occasional closely spaced ZHP-3 foci represent multiple sites along the same chromosome.

> 4\) Subsection "Association of ZHPs with meiotic chromosomes depends on synaptonemal complexes". The authors should define what they mean by CO designation, how it is monitored and what is the basis for assuming that COSA-1 and MSH-5 are required for CO designation.

We thank the reviewers for pointing out these ambiguities in our terminology. Prior work has established that COSA-1, ZHP-3, and MutSƔ are not required for synapsis in *C. elegans* but are all required for the appearance of bright COSA-1 foci along chromosomes at mid-pachytene, which have been convincingly established to correspond to sites of designated crossovers. Operationally, crossover designation is thus defined as the appearance of bright COSA-1 foci after mid-pachytene. COSA-1 and MutSƔ are also interdependent for the appearance of early foci that stain faintly with MSH-5 antibodies (MSH-4 antibodies and tagged transgenes have not produced signals above the limit of our detection). In the revised manuscript we show that ZHP-3/4 are also required for detection of these early, dim foci. Given that the biochemical basis for this designation remains uncertain, we have now largely eliminated the phrase "crossover designation," and instead used more descriptive phrases such as "bright COSA-1 foci," throughout the manuscript. Evidence from other organisms suggests that crossover designation and crossover resolution/maturation may be temporally distinct processes, so we have also avoided the use of the term "crossover formation" to describe the sites marked by COSA-1 foci.

> 5\) Subsection "ZHPs act as two heterodimeric complexes". Head of section should be revised. The data presented does not show that the complexes are heterodimeric.

We have provided complementary lines of evidence that these proteins act as heterodimers: in addition to showing that the four ZHPs show pairwise interdependence for their localization and function, and in some cases for stability, we provide physical interaction data based on yeast 2-hybrid analysis, which is generally regarded as reporting on direct protein-protein interactions (Fields and Song, (1989). A novel genetic system to detect protein-protein interactions PMID: 2547163 DOI:10.1038/340245a0). Based on ample precedents for dimerization of RING finger E3 ligases, our evidence supports the idea that these proteins function as heterodimers or heterooligomers.

However, to soften the statement, we have revised the section heading to read: "ZHPs likely act as two heterodimeric complexes."

> 6\) Subsection "ZHP-3/4 are essential for CO designation, while ZHP-1/2 limit ZHP-3/4 activity and promote CO maturation". The dim COSA-1 foci observed in zhp-1/2 mutants should be clarified. This is an essential point since the authors conclude based on this observation that ZHPs limit CO. However, the Spo11 dependency does not tell whether these foci are DSB repair sites. Co-staining with DSB repair protein should be tested (RAD-51, RPA). These foci are obviously not converted into CO. MSH5 foci (Figure 4---figure supplement 1) appear substantially brighter in the zhp-1/2 mutants. Is this correct or a matter of image adjustment/exposure? Do they vary in size/brightness? The increase from mid to late pachytene is not visible on Figure 4---figure supplement 1. Their numbers also appear to be higher than previous various estimates of DSB events.
>
> The authors may consider the possibility that MSH-5 foci are transient or destabilized in zhp-3 (4) mutant.

We thank the reviewers for highlighting this issue, and we provide additional information to clarify this in the revised manuscript. Specifically, we have now co-stained for COSA-1 and RAD-51 ([Author response image 1](#respfig1){ref-type="fig"}) and for COSA-1 and MSH-5 (Figure 4---figure supplement 1E) in *zhp-1* mutants. We find that COSA-1 foci do not colocalize with RAD-51 (as is also true for wild-type *C. elegans*). However, we found that dim COSA-1 foci do colocalize extensively with MSH-5. Together with our findings that these foci are absent or greatly reduced in *spo-11* and *dsb-2* mutants, respectively, this supports the idea that dim COSA-1 foci correspond to recombination intermediates.

![](elife-30789-resp-fig1){#respfig1}

Indeed, MSH-5 foci (Figure 4---figure supplement 1) appear substantially brighter in the *zhp-1/2* mutants, which likely reflects a failure of the "winner takes all" nature of the ZHP circuit. The increase in MSH-5 intensity from mid to late pachytene is much more obvious in *zhp-1* mutants than in WT. The brightness of MSH-5 foci can vary markedly in the same nucleus. While we have quantified the relative numbers of these foci in *zhp-1/2* vs. wild-type animals, we do not feel that these can be regarded as absolute numbers of intermediates, due to the limits of fluorescent detection, particularly for proteins of low abundance (as argued above). We also now report that early MSH-5 and COSA-1 foci are not detected in *zhp-3/4* mutants and suggest that this may be due to a failure of stabilization.

Quantification of DSBs in *C. elegans* has been challenging and contentious. Again, different markers (e.g., MSH-5 vs. RAD-51) have different sensitivities of detection. Additionally, mutations that block the repair of DSBs in *C. elegans* (e.g., *rad-54*) lead to a prolonged period of DSB formation and an increase in their number, making it very difficult to assess this question, and we are not aware of any reliable estimates for the number of DSBs in wild-type animals. (See our discussion of this issue in Yu et al., 2016). We are working to address this important question by immunoprecipitating SPO-11-bound oligonucleotides.

> 7\) The impact of ZHP-1/2 on axis remodeling is not convincing. The statement that HTP-1 and SYP-1 remain colocalized in zhp-1 mutant (Figure 6---figure supplement 1B) is not seen on the figure (Figure 6---figure supplement 1B) where only a fraction of the proteins colocalizes in nucleus \#2.
>
> The authors conclude that in the absence of ZHP-1/2, SC remodeling on axis is defective (with persistence on both short on long arms), but this is not the case in the context of DSB-2. Thus, there is a ZHP-1/2 independent remodeling of SC proteins? Please clarify and revise the statement \"ZHP-1/2 mediate chromosome remodeling\".

We recognize that it can be difficult, particularly for researchers unfamiliar with meiotic cytology in *C. elegans*, to appreciate and interpret the differences in bivalent structure we document for various genotypes. We have tried to clarify the text and figure legends to make the images easier to interpret. Our key findings are that HTP-1 and SYP-1 fail to show reciprocal localization on the few bivalent chromosomes present in *zhp-1/2* mutants, and also colocalize along univalent chromosomes. In contrast, in other mutants lacking COs, univalent chromosomes are usually positive for HTP-1 or SYP-1 staining, but not both (Martinez-Perez et al., ‎2005).

We used *zhp-1/2; dsb-2* double mutants to analyze this issue further, since in these animals we do observe occasional bright COSA-1 foci at late pachytene. These foci correspond to the number of bivalents observed at diakinesis, indicating that they mature as crossovers. Although ZHP-3/4 were depleted from the corresponding SCs, other hallmarks of remodeling (e.g., PLK-2 localization and SC retention along the short arms) were defective, leading to the hierarchical view of remodeling described in the text and in Figure 8.

We hope that these clarifications fully address the reviewers' concerns.

> 8\) Subsection "Conservation of crossover control mechanisms". Clarify what is meant by \"Evidence presented here\[...\]\": Which data indicate that ZHP activity is responsible for signal propagation in crossover interference? How does this idea explain the dosage sensitivity of RNF212/HEI10?

We have removed this statement, since we agreed that it was confusing and that other interpretations are equally consistent with our data. We address the dosage sensitivity of RNF212/HEI10 in the Discussion section.

> 9\) Figure 1---figure supplement 2: Western blots: why normalizing by HTP-3 if the level of this protein is not the same in wt and syp1? Tubulin should be used. Then revise subsection "Association of ZHPs with meiotic chromosomes depends on synaptonemal complexes" about the abundance of these proteins.
>
> Provide statistical analysis of the differences in protein levels. Figure 1---figure supplement 2 legend: replace overestimates by underestimates or delete

We thank the reviewers for pointing out this. We routinely load lysate from an equal number of age-matched worms in each lane, which is probably at least as useful as other normalization methods. The abundance of many proteins, including tubulin, is affected by meiotic mutations such as *syp-1*, presumably due to differential abundance of proliferating and meiotic stages in the germline. Using tubulin and HTP-3 to normalize our ZHP blots gave very similar results ([Author response image 2](#respfig2){ref-type="fig"}). We chose to include HTP-3 as reference, since this protein is restricted to nuclei in meiotic prophase, while tubulin is present in all germline and somatic cells. Because both HTP-3 and tubulin are more abundant in *syp-1* mutants, our normalized measurements likely underestimate the degree to which the ZHP proteins are reduced/destabilized in the absence of synapsis. However, this is not a central finding of this work.

![](elife-30789-resp-fig2){#respfig2}

> 10\) Subsection "ZHPs play essential roles in chiasma formation and chromosome segregation". It is argued you that zhp-1/2 are more viable than zhp-3, is it statistically significant?

Yes, it is clearly significant. We have added p values based on Student's *t*-test in the revised manuscript.

> 11\) Figure 3---figure supplement 1G, H, I, J. For RAD-51 foci, present scatter graphs showing the 4 data points.

We have replaced the previous bar graphs by the new scatter graphs (Figure 3---figure supplement 3C-F in the new version of manuscript). However, we think that the bar graphs are actually easier to read, so we would like to leave the bar graphs in this response letter ([Author response image 3](#respfig3){ref-type="fig"}).

![](elife-30789-resp-fig3){#respfig3}

> 12\) Figure 3 statistical tests and P values should be provided for the distributions in A-D.

We have now analyzed these distributions using the Chi-square test. The results and p values are provided in the figure legend.

> 13\) Figure 5 panel D, Figure 5---figure supplement 1 Panel C. COSA-1 foci should be quantified

We thank the reviewers for this suggestion. However, we feel that this would be impossible to do in a meaningful way due to the sensitivity issues raised above. As we describe, as we exposed animals to increasing doses of radiation, the number of dim foci increased, and bright foci decreased. However, the brightness of the foci in the same nuclei varies widely, making it impossible to classify them. Additionally, it should be noted that all published COSA-1 quantification to date has used a bombarded (multicopy) GFP-COSA-1 transgene, which is likely overexpressed relative to wild-type COSA-1 and may therefore not represent the wild-type situation. That said, we have quantified COSA-1 foci in Figure 5 panel A, which strongly support our conclusion. Figure 5 panel D was included to document the gradual change in both brightness and number of COSA-1 foci, since the images provide a better understanding than any quantification.

> 14\) Subsection "Conservation of crossover control mechanisms". SUMO or ubiquitin ligase activities of these proteins have not been established. This statement should be removed.

We agree that there are no published findings that convincingly establish SUMO or ubiquitin ligase activity for the Zip3/RNF212/Hei10/ZHP family. However, interpretations in several prominent publications have led many in the field to accept the idea that these proteins have opposing SUMO and ubiquitin ligase activity. We thus feel that it is relevant and important to highlight prior findings from *C. elegans* that indicate that SUMOylation is dispensable for crossover control in this organism. We have removed comments about the likely activities of homologs in other organisms.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> One important point that needs to be revised in accordance with eLife editorial policy is the Abstract. Although the Abstract can certainly highlight the general conclusion about the regulatory network, it must report the key experimental findings (ie the CO controls, designation and maturation, by Zhp-1/Zhp-2 and by Zhp-3 and Zhp-4, the compartmentalization and its asymmetry...).
>
> In addition, several sentences of the abstract should be revised:
>
> It should be acknowledged that one member, Zhp-3, was already identified.
>
> The term \"stepwise segregation\" should be changed as it will be obscure for most readers.
>
> The use of \"winners-takes-all\" is not specifically explanatory because one is left with the question of who wins and what does it take to win?
>
> The evolutionary conservation is also not properly reported in this abstract since it was already supported by previous work in mammals, yeast and sordaria.

We thank the reviewer for these suggestions. We have now revised the Abstract extensively to address these comments. Specifically, we now mention the conserved role of the ZHP family of proteins, the prior evidence that ZHP-3 is required for crossovers, and compartmentalization of these factors within the synaptonemal complex. To include these ideas while keeping the Abstract within 150 words, it was necessary to remove some of the other statements. We have deleted the sentence regarding the winner-takes-all nature of the circuit, since it requires more space than available in the Abstract to clarify, but we do still mention this idea in the Discussion section. (We note that "winner-take-all" is a well-established term that describes a class of regulatory mechanisms). We also removed the phrase "stepwise segregation" from the Abstract, for similar reasons.

> 1\) In the main text, change the term « meiotic cohesion » which cannot be understood as such.

The reviewers have not explained why they object to this term, but to address this comment we have now replaced the phrase "meiotic cohesion" with "sister chromatid cohesion in meiosis" or similar alternatives throughout the manuscript.

> 2\) Subsection "A family of meiotic RING finger proteins in C. elegans", third paragraph. Three data not shown are referred to. Please show homology to mammalian RNF212 and to Hei10 and add the information in Figure 1---figure supplement 1.

We appreciate this suggestion. However, we made a decision not to include alignments, phylogenetic trees, or other visual evidence for homology between ZHPs, Zip3, RNF212, and HEI10 because we find that these alignments are highly sensitive to the specific algorithms and parameters chosen. Unsurprisingly, the well-conserved RING finger domains dominate any alignments among these proteins. Coiled-coil domains are notoriously refractory to homology recognition and alignment because they have a highly skewed amino acid composition. The highly divergent, probably unstructured, C-terminal domains likely confer the unique activities of these proteins, but are difficult to align meaningfully, in part because such domains do not conform to the same patterns of amino acid substitutions as globular protein domains. The sequences of the ZHP proteins and their homologs are readily available, so interested readers can easily and quickly verify homology by doing their own BLAST or other homology searches and alignments, using the tools they prefer.

> 3\) It would help if the authors emphasize that the compartment they refer to is a bivalent with its SC and thus conveys bivalent autonomous properties. This is mentioned in subsection "ZHP-1/2 mediate chromosome remodeling in response to CO designation", but it could also be mentioned subsection "Compartmentalization of CO regulation by the synaptonemal complex".

By \"compartment" we actually mean the SC that assembles between a pair of chromosomes (or an individual polycomplex), rather than the bivalent as a whole. We have added additional comments in several places, including the abstract, to clarify our use of this term.

> 4\) In the Introduction, add \"likely\" heterodimeric to qualify the protein complexes.

We have added "likely" to qualify this statement. We note that the reviewers have not explained their skepticism about the idea that ZHP-1/2 and ZHP-3/4 are heterodimeric complexes, given that we provide extensive physical and functional interaction data and there are many precedents for dimerization of RING finger proteins.

> 5\) Introduction. Whether it is poorly understood is subjective, the authors should rather acknowledge what is known (work on RNF212 and HEI10) or not.

We have removed the comment.

> 6\) Data of the quantification of Zhp-4 and Cosa foci should be provided to support the sentence "At late pachynema, all GFP-COSA-1 foci colocalize with ZHP-4 puncta in 100% of nuclei (n=450 nuclei, 11 rows of nuclei from 8 gonads were scored). 3F indicates 3xFLAG. Scale bars, 5μm." (Figure 1 legend).

We do not understand what the reviewers are requesting here. Figure 1 includes representative images showing colocalization of COSA-1 with ZHP-3 and ZHP-4 at late pachytene. The legend describes our quantification of the extent of colocalization between COSA-1 and ZHP-4 at this stage (as previously requested by the reviewers), including the numbers of nuclei and gonads analyzed. We felt that including this statement in the main text disrupted the flow, so we chose to put it in the figure legend, but we can move it to the main text if preferred.

> 7\) Ambiguity persists on the use of CO designation and maturation and the criteria used for monitoring this.

We have now replaced most of the remaining instances of the phrase "CO designation" with the more objective "accumulation of pro-CO factors at a single site" or similar.

> Subsection "ZHP proteins exhibit two distinct patterns of dynamic localization during meiosis": CO designation is thought to occur at mid pachytene
>
> However, the criteria for CO designation is bright COSA-1 foci which are fully detected at late pachynema (It should be mentioned that the criteria for CO maturation is chiasma or genetic exchange). (Subsection "Subsection "ZHP proteins exhibit two distinct patterns of dynamic localization during meiosis": Upon the appearance of GFP COSA-1 foci, which mark designated crossover sites).

In this particular context, our statements summarize the conclusions of Yokoo et al., (2012). While COSA-1 foci normally become brighter from mid to late pachytene, the accumulation of COSA-1 at a single site initiates by mid-pachytene, indicating that the site has been selected/designated at that time.

> The use of « robust » CO designation is also confusing (subsection "ZHP-3/4 are essential to stabilize CO intermediates, while ZHP-1/2 restrict pro-CO activities") because it is also used to relate to the brightness of COSA-1 foci (Subsection "ZHP-1/2 mediate chromosome remodeling in response to CO designation": COs were robustly marked by COSA-1).
>
> In Zhp-1 mutant bright COSA-1 foci are absent but still some low level of CO is detected. I assume the authors want to suggest that CO designation is not completely abolished in Zhp-1 mutant (robust is also used to qualify interference and maturation).

We have removed the adjective "robust" from our descriptions of the crossover designation process, and we have also eliminated the phrase "crossover designation," as noted above. It remains unclear why some COs are detected (by both genetic recombination analysis and the presence of bivalents at diakinesis) in *zhp-1/2* mutants, even though we do not observe accumulation of pro-CO factors at a subset of recombination intermediates. It may be that sufficient pro-CO factors stochastically accumulate at a subset of sites to promote CO maturation through the Class I pathway, or these COs may instead be Class II COs, which have been observed in some *C. elegans* mutants. This ambiguity makes it difficult to say whether "CO designation" in the presence of excess DSBs strictly depends on *zhp-1/2*. Our experiments with *dsb-2* mutants indicate that the roles of *zhp-1/2* are less essential for accumulation of pro-CO factors at recombination intermediates when competition between these intermediates is reduced or eliminated.
